[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"_public_publisher_byId_00349129-11c9-4a07-8059-ff2c4a098cda":3,"_public_publication_all{\"sortAscending\":false,\"sortField\":\"updateTime\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"publisherId:00349129-11c9-4a07-8059-ff2c4a098cda,\"}":92},{"code":4,"data":5,"meta":18},"SUCCESS",{"id":6,"createTime":7,"updateTime":8,"relativeEntities":9,"slug":10,"properties":11,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":20,"manageAffiliations":29,"indexDatabases":53,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},"00349129-11c9-4a07-8059-ff2c4a098cda","2023-12-05T05:30:09.024+00:00","2025-11-21T09:58:13.485+00:00",[],"Kidney-International",{"issn":12,"title":14},{"VOID":13},"00852538",{"EN":15},"Kidney International","PUBLISHER","PENDING",null,0,[21],{"id":22,"createTime":23,"updateTime":24,"relativeEntities":25,"label":26,"description":28,"parentId":18,"standard":18,"scholarHubFieldId":18},"7f9a0404-9be1-4b5a-aaf2-7d77f9c711d2","2023-05-29T10:25:13.226+00:00","2023-11-21T05:26:08.502+00:00",[],{"EN":27},"Nephrology",{},[30,42],{"id":31,"createTime":32,"updateTime":33,"relativeEntities":34,"slug":35,"properties":36,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":40,"url":18,"parentIds":41,"statistic":18},"18aff490-2422-46f1-a98d-c061dab6256d","2023-05-29T10:24:02.566+00:00","2025-11-21T10:07:49.466+00:00",[],"Elsevier-Inc-",{"title":37},{"EN":38},"Elsevier Inc.","AFFILIATION",10,[],{"id":43,"createTime":44,"updateTime":45,"relativeEntities":46,"slug":47,"properties":48,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":51,"url":18,"parentIds":52,"statistic":18},"88620e1c-4e83-45c7-9895-c9773cdc5cb4","2023-05-29T12:06:08.191+00:00","2023-12-20T08:29:46.587+00:00",[],"ELSEVIER-SCIENCE-INC",{"title":49},{"EN":50},"ELSEVIER SCIENCE INC",30,[],[54,73],{"id":55,"indexDatabase":56,"url":68,"indexYears":69,"academicFieldIds":70,"indexDatabaseRanking":72},"67970c36-8a88-45ea-972a-e31f9824b936",{"id":57,"createTime":58,"updateTime":59,"relativeEntities":60,"label":61,"description":63,"key":65,"publicationTags":66,"standard":18},"3c7051d4-eb7d-4c57-a56b-36fc74c5d1e9","2023-05-22T09:57:18.509+00:00","2025-11-21T10:07:52.274+00:00",[],{"EN":62,"VI":62},"Scopus - Elsevier",{"EN":62,"VI":64},"Cơ sở dữ liệu Scopus thuộc Elsevier","scopus",[67],"SCOPUS","https:\u002F\u002Fwww.scopus.com\u002Fsourceid\u002F19992","1972-2025",[71],"f5767906-2ea6-4405-84ce-f4d1924a0b55","SCOPUS__Q1",{"id":74,"indexDatabase":75,"url":89,"indexYears":18,"academicFieldIds":90,"indexDatabaseRanking":18},"2b498ad8-3875-439a-9227-6cc8c090e524",{"id":76,"createTime":77,"updateTime":78,"relativeEntities":79,"label":80,"description":82,"key":85,"publicationTags":86,"standard":18},"a4921856-b128-4d9f-8f1f-e80813d3bbd4","2023-05-22T09:59:31.026+00:00","2025-11-21T10:07:52.153+00:00",[],{"EN":81,"VI":81},"ISI\u002FSCIE - Science Citation Index Expanded",{"VI":83,"EN":84},"Cơ sở dữ liệu SCIE","SCIE database","scie",[87,88],"SCIE","ISI","https:\u002F\u002Fmjl.clarivate.com\u002Fsearch-results?issn=0085-2538",[91],"89bd3143-34da-4e0c-a662-528d683c514f",{"meta":93,"data":95},{"total":94},"8271",[96,214,373,448,495,569,629,737,823,883],{"id":97,"createTime":98,"updateTime":99,"relativeEntities":100,"slug":101,"properties":102,"entityType":109,"verifyStatus":110,"verifyTime":99,"verifyNote":111,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":112,"fullTextUrl":18,"authors":113,"publicationType":182,"publisherRelationship":183,"citationCount":18,"citationInfo":18,"publishDate":211,"publishYear":212,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":213},"543359b2-76e3-40a2-9a59-3d75a433e1a3","2024-01-16T07:07:12.730+00:00","2025-01-12T23:59:51.688+00:00",[],"Induction-of-insulin-resistance-in-normal-adipose-tissue-by-uremic-human-serum",{"references":103,"title":105,"doi":107},{"VOID":104},"DeFronzo, 1973, Carbohydrate metabolism in uremia. A review, Medicine, 52, 469, 10.1097\u002F00005792-197309000-00009\nWestervelt, 1968, Abnormal carbohydrate metabolism in uremia, Am J Clin Nutr, 21, 423, 10.1093\u002Fajcn\u002F21.5.423\nDeFronzo, 1978, Glucose intolerance in uremia, J Clin Invest, 62, 425, 10.1172\u002FJCI109144\nMaloff, 1983, Cellular basis for insulin resistance in chronic uremia, Am J Physiol, 245, E178\nHampers, 1966, Effect of chronic renal failure and hemodialysis on carbohydrate metabolism, J Clin Invest, 45, 1719, 10.1172\u002FJCI105478\nBalestri, 1972, Effects of uraemic serum, urea, creatinine and methylguanidine on glucose metabolism, Clin Sci, 42, 395, 10.1042\u002Fcs0420395\nMorgan, 1964, Study of the effect of uremic metabolites on erythrocyte glycolysis, Metabolism, 13, 629, 10.1016\u002F0026-0495(64)90071-X\nDzurik, 1980, Metabolic alterations caused by uremia, Proc Eur Dial Transplant Assoc, 17, 577\nInternational Committee for Nomenclature and Nosology of Renal Disease, 1975\nNational Diabetes Data Group, 1979, Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance, Diabetes, 28, 1039, 10.2337\u002Fdiab.28.12.1039\nRodbell, 1964, Metabolism of isolated fat cells. I. Effects of hormones on glucose metabolism and lipolysis, J Biol Chem, 239, 375, 10.1016\u002FS0021-9258(18)51687-2\nGliemann, 1972, A procedure for measurement of distribution spaces in isolated fat cells, Biochim Biophys Acta, 286, 1, 10.1016\u002F0304-4165(72)90082-7\nMoody, 1974, A simple free fat cell bioassay for insulin, Horm Metab Res, 6, 12, 10.1055\u002Fs-0028-1093895\nSturgeon, 1979, Improved spectrophotometric determination of glycerol and its comparison with an enzymatic method, J Pharm Sci, 68, 1064, 10.1002\u002Fjps.2600680841\nHerington, 1974, Radioreceptor and radioimmunoassay quantitation of human growth hormone in agromegalic serum: Overestimate by immunoassay and systematic differences between antisera, J Clin Endocrinol Metab, 39, 257, 10.1210\u002Fjcem-39-2-257\nInsogna, 1981, Effect of age on serum immunoreactive parathyroid hormone and its biologic effects, J Clin Endocrinol Metab, 53, 1072, 10.1210\u002Fjcem-53-5-1072\nMirsky, 1959, The destruction of glucagon, adrenocorticotropin and somatotropin by human blood plasma, J Clin Invest, 38, 14, 10.1172\u002FJCI103783\nMaloff, 1980, Direct effects of growth hormone on insulin action in rat adipose tissue maintained in vitro, Endocrinology, 107, 538, 10.1210\u002Fendo-107-2-538\nMalchoff, 1982, Influence of dexamethasone on insulin action: Inhibition of basal and insulin-stimulated hexose transport is dependent on length of exposure in vitro, Endocrinology, 110, 2081, 10.1210\u002Fendo-110-6-2081\nKahn, 1978, Insulin resistance, insulin insensitivity, and insulin unresponsiveness: A necessary distinction, Metabolism, 27, 1893, 10.1016\u002FS0026-0495(78)80007-9\nSmith, 1982, Insulin resistance in uremia mediated by postbinding defects, Kidney Int, 22, 54, 10.1038\u002Fki.1982.132\nBolinder, 1982, Postreceptor defects causing insulin resistance in normoinsulinemic non-insulin-dependent diabetes mellitus, Diabetes, 31, 911, 10.2337\u002Fdiab.31.10.911\nKolterman, 1980, Mechanisms of insulin resistance in human obesity, J Clin Invest, 65, 1272, 10.1172\u002FJCI109790\nSherwin, 1976, Influence of uremia and hemodialysis on the turnover and metabolic effects of glucagon, J Clin Invest, 57, 722, 10.1172\u002FJCI108330\nRizza, 1982, Effects of growth hormone on insulin action in man, Diabetes, 31, 663, 10.2337\u002Fdiab.31.8.663\nLindall, 1971, Insulin hypersecretion in patients on chronic hemodialysis. Role of parathyroids, J Clin Endocrinol Metab, 32, 653, 10.1210\u002Fjcem-32-5-653\nConn, 1956, Influence of adrenal cortical steroids on carbohydrate metabolism in man, Metabolism, 5, 114\nDeFronzo, 1979, The role of growth hormone in the glucose intolerance of uremia, Acta Diabetol Lat, 16, 279, 10.1007\u002FBF02587648",{"EN":106},"Induction of insulin resistance in normal adipose tissue by uremic human serum",{"VOID":108},"10.1038\u002Fki.1984.33","PUBLICATION","VERIFIED","Auto Verify","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0085253815331422",[114,130,143,156,169],{"id":115,"sortIndex":19,"researcher":18,"roles":116,"affiliations":118,"properties":127},"75260527-e88d-4d33-b78e-b3d416980376",[117],"AUTHOR",[119],{"id":18,"sortIndex":19,"affiliation":120,"properties":18},{"id":121,"createTime":122,"updateTime":122,"relativeEntities":123,"slug":18,"properties":124,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"c25f434a-3595-407e-89a8-72abf925428f","2024-01-16T07:07:12.761+00:00",[],{"title":125},{"VI":126},"Endocrine-Metabolism and Nephrology Units, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York",{"title":128},{"VI":129},"Michael L. McCaleb",{"id":131,"sortIndex":132,"researcher":18,"roles":133,"affiliations":134,"properties":140},"52086adb-bfe6-456d-aa1d-abf8dec78d10",3,[117],[135],{"id":18,"sortIndex":19,"affiliation":136,"properties":18},{"id":121,"createTime":122,"updateTime":122,"relativeEntities":137,"slug":18,"properties":138,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":139},{"VI":126},{"title":141},{"VI":142},"Margaret S. Izzo",{"id":144,"sortIndex":145,"researcher":18,"roles":146,"affiliations":147,"properties":153},"86996bf1-0d67-44c9-97dc-df5d9ff7bb9d",2,[117],[148],{"id":18,"sortIndex":19,"affiliation":149,"properties":18},{"id":121,"createTime":122,"updateTime":122,"relativeEntities":150,"slug":18,"properties":151,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":152},{"VI":126},{"title":154},{"VI":155},"Richard B. Freeman",{"id":157,"sortIndex":158,"researcher":18,"roles":159,"affiliations":160,"properties":166},"1c1049cc-5b55-4e4f-9b42-3a34057fe010",4,[117],[161],{"id":18,"sortIndex":19,"affiliation":162,"properties":18},{"id":121,"createTime":122,"updateTime":122,"relativeEntities":163,"slug":18,"properties":164,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":165},{"VI":126},{"title":167},{"VI":168},"Dean H. Lockwood",{"id":170,"sortIndex":171,"researcher":18,"roles":172,"affiliations":173,"properties":179},"94e323a2-f23a-4a41-8cfd-9a3428cd361e",1,[117],[174],{"id":18,"sortIndex":19,"affiliation":175,"properties":18},{"id":121,"createTime":122,"updateTime":122,"relativeEntities":176,"slug":18,"properties":177,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":178},{"VI":126},{"title":180},{"VI":181},"Robert Mevorach","ARTICLE",{"url":112,"publisher":184,"properties":206},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":185,"slug":10,"properties":186,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":189,"manageAffiliations":190,"indexDatabases":191,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":187,"title":188},{"VOID":13},{"EN":15},[],[],[192,199],{"id":55,"indexDatabase":193,"url":68,"indexYears":69,"academicFieldIds":198,"indexDatabaseRanking":72},{"id":57,"createTime":58,"updateTime":59,"relativeEntities":194,"label":195,"description":196,"key":65,"publicationTags":197,"standard":18},[],{"EN":62,"VI":62},{"EN":62,"VI":64},[67],[71],{"id":74,"indexDatabase":200,"url":89,"indexYears":18,"academicFieldIds":205,"indexDatabaseRanking":18},{"id":76,"createTime":77,"updateTime":78,"relativeEntities":201,"label":202,"description":203,"key":85,"publicationTags":204,"standard":18},[],{"EN":81,"VI":81},{"VI":83,"EN":84},[87,88],[91],{"volume":207,"pages":209},{"VOID":208},"25",{"VOID":210},"416-421","1984-02-01",1984,false,{"id":215,"createTime":216,"updateTime":217,"relativeEntities":218,"slug":219,"properties":220,"entityType":109,"verifyStatus":110,"verifyTime":217,"verifyNote":111,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":227,"fullTextUrl":18,"authors":228,"publicationType":182,"publisherRelationship":343,"citationCount":18,"citationInfo":18,"publishDate":371,"publishYear":372,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":213},"1bcaf4f1-28b5-4bdd-9b7b-ba48ce6409c6","2024-01-09T00:09:12.567+00:00","2025-01-14T23:59:42.622+00:00",[],"A-simple-score-predicts-future-cardiovascular-events-in-an-inception-cohort-of-dialysis-patients",{"references":221,"title":223,"doi":225},{"VOID":222},"Goodman, 2000, Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis, N Engl J Med, 342, 1478, 10.1056\u002FNEJM200005183422003\nOh, 2002, Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure, Circulation, 106, 100, 10.1161\u002F01.CIR.0000020222.63035.C0\nHunt, 2002, Bone formation in carotid plaques: a clinicopathological study, Stroke, 33, 1214, 10.1161\u002F01.STR.0000013741.41309.67\nSangiorgi, 1998, Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using nondecalcifying methodology, J Am Coll Cardiol, 31, 126, 10.1016\u002FS0735-1097(97)00443-9\nSchwaiger, 2006, Carotid plaques and their predictive value for cardiovascular disease and all-cause mortality in hemodialysis patients considering renal transplantation – a decade follow-up, Am J Kidney Dis, 47, 888, 10.1053\u002Fj.ajkd.2006.01.011\nShanahan, 1999, Medial localization of mineralization-regulating proteins in association with Monckeberg's sclerosis: evidence for smooth muscle cell-mediated vascular calcification, Circulation, 100, 2168, 10.1161\u002F01.CIR.100.21.2168\nIshimura, 2002, Different risk factors for peripheral vascular calcification between diabetic and non-diabetic haemodialysis patients – importance of glycaemic control, Diabetologia, 45, 1446, 10.1007\u002Fs00125-002-0920-8\nWang, 2001, Association of inflammation and malnutrition with cardiac valve calcification in continuous ambulatory peritoneal dialysis patients, J Am Soc Nephrol, 12, 1927, 10.1681\u002FASN.V1291927\nBlock, 1998, Association of serum phosphorus and calcium × phosphate product with mortality risk in chronic hemodialysis patients: a national study, Am J Kidney Dis, 31, 607, 10.1053\u002Fajkd.1998.v31.pm9531176\nJono, 2000, Phosphate regulation of vascular smooth muscle cell calcification, Circ Res, 87, E10, 10.1161\u002F01.RES.87.7.e10\nChertow, 2004, Determinants of progressive vascular calcification in haemodialysis patients, Nephrol Dial Transplant, 19, 1489, 10.1093\u002Fndt\u002Fgfh125\nNational Kidney Foundation, 2003, K\u002FDOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease, Am J Kidney Dis, 42, S1, 10.1016\u002FS0272-6386(03)00905-3\nBlacher, 2001, Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease, Hypertension, 38, 938, 10.1161\u002Fhy1001.096358\nLondon, 2003, Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality, Nephrol Dial Transplant, 18, 1731, 10.1093\u002Fndt\u002Fgfg414\nAdragao, 2004, A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients, Nephrol Dial Transplant, 19, 1480, 10.1093\u002Fndt\u002Fgfh217\nWolfe, 1999, Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant, N Engl J Med, 341, 1725, 10.1056\u002FNEJM199912023412303\nQunibi, 2005, Cardiovascular calcification in Hispanic Americans (HA) with chronic kidney disease (CKD) due to type 2 diabetes, Kidney Int, 68, 271, 10.1111\u002Fj.1523-1755.2005.00402.x\nMoe, 2003, Assessment of vascular calcification in ESRD patients using spiral CT, Nephrol Dial Transplant, 18, 1152, 10.1093\u002Fndt\u002Fgfg093\nBrookmeyer, 1987, Biases in prevalent cohorts, Biometrics, 43, 739, 10.2307\u002F2531529\nHernandez, 2005, Clinical impact of preexisting vascular calcifications on mortality after renal transplantation, Kidney Int, 67, 2015, 10.1111\u002Fj.1523-1755.2005.00303.x\nMcIntyre, 2006, Is it practical to screen dialysis patients for vascular calcification?, Nephrol Dial Transplant, 21, 251, 10.1093\u002Fndt\u002Fgfi227\nBraun, 1996, Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients, Am J Kidney Dis, 27, 394, 10.1016\u002FS0272-6386(96)90363-7\nSigrist, 2006, Vascular calcification and cardiovascular function in chronic kidney disease, Nephrol Dial Transplant, 21, 707, 10.1093\u002Fndt\u002Fgfi236\nDetrano, 1999, Coronary calcium does not accurately predict near-term future coronary events in high-risk adults, Circulation, 99, 2633, 10.1161\u002F01.CIR.99.20.2633\nSharples, 2004, Coronary artery calcification measured with electron-beam computerized tomography correlates poorly with coronary artery angiography in dialysis patients, Am J Kidney Dis, 43, 313, 10.1053\u002Fj.ajkd.2003.10.035\nBecker, 2000, Helical and single-slice conventional CT versus electron beam CT for the quantification of coronary artery calcification, Am J Roentgenol, 174, 543, 10.2214\u002Fajr.174.2.1740543\nKronenberg, 2003, Prevalence and progression of peripheral arterial calcifications in patients with ESRD, Am J Kidney Dis, 41, 140, 10.1053\u002Fajkd.2003.50033\nKronenberg, 1994, Effect of sample storage on the measurement of lipoprotein(a), apolipoproteins B and A-IV, total and high-density lipoprotein cholesterol and triglycerides, J Lipid Res, 35, 1318, 10.1016\u002FS0022-2275(20)39975-2\nTherneau, 2000",{"EN":224},"A simple score predicts future cardiovascular events in an inception cohort of dialysis patients",{"VOID":226},"10.1038\u002Fsj.ki.5001589","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0085253815519704",[229,245,270,288,307,319,331],{"id":230,"sortIndex":231,"researcher":18,"roles":232,"affiliations":233,"properties":242},"f6f6d650-2023-4e1b-80fc-bc76b2a6eedf",6,[117],[234],{"id":18,"sortIndex":19,"affiliation":235,"properties":18},{"id":236,"createTime":237,"updateTime":237,"relativeEntities":238,"slug":18,"properties":239,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"0d4623eb-55a9-484f-b32e-d5cc656ee744","2024-01-09T00:09:12.574+00:00",[],{"title":240},{"VI":241},"Department of Medical Genetics, Molecular and Clinical Pharmacology, Division of Genetic Epidemiology, Innsbruck Medical University, Innsbruck, Austria",{"title":243},{"VI":244},"F. Kronenberg",{"id":246,"sortIndex":171,"researcher":18,"roles":247,"affiliations":248,"properties":267},"7251a4b4-ffb5-4348-9843-2bd526caf344",[117],[249,259],{"id":250,"sortIndex":171,"affiliation":251,"properties":258},"4d79f59c-1423-4b95-a306-116782889e67",{"id":252,"createTime":253,"updateTime":253,"relativeEntities":254,"slug":18,"properties":255,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"9a5a885c-ca60-4eb6-9619-9660f367e997","2024-01-09T00:09:12.601+00:00",[],{"title":256},{"VI":257},"Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT) Feldkirch, Feldkirch, Austria",{},{"id":18,"sortIndex":19,"affiliation":260,"properties":18},{"id":261,"createTime":262,"updateTime":262,"relativeEntities":263,"slug":18,"properties":264,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"121dada6-471d-4fae-aac1-66d0eb4c72df","2024-01-09T00:09:12.582+00:00",[],{"title":265},{"VI":266},"Department of Nephrology and Dialysis, Feldkirch Hospital, Feldkirch, Austria",{"title":268},{"VI":269},"U. Neyer",{"id":271,"sortIndex":272,"researcher":18,"roles":273,"affiliations":274,"properties":285},"c7da3422-789f-42ef-bb43-91e504798617",5,[117],[275],{"id":18,"sortIndex":19,"affiliation":276,"properties":18},{"id":277,"createTime":278,"updateTime":279,"relativeEntities":280,"slug":281,"properties":282,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"0664997a-ed2b-4aab-b66d-efeb89c2f04b","2024-01-09T00:09:12.626+00:00","2025-06-11T19:28:30.834+00:00",[],"Department-of-Radiology-Feldkirch-Hospital-Feldkirch-Austria",{"title":283},{"VI":284},"Department of Radiology, Feldkirch Hospital, Feldkirch, Austria",{"title":286},{"VI":287},"M. Längle",{"id":289,"sortIndex":145,"researcher":18,"roles":290,"affiliations":291,"properties":304},"81c9263a-d8dc-4263-a70f-1eaed1529fe4",[117],[292,297],{"id":18,"sortIndex":19,"affiliation":293,"properties":18},{"id":261,"createTime":262,"updateTime":262,"relativeEntities":294,"slug":18,"properties":295,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":296},{"VI":266},{"id":298,"sortIndex":171,"affiliation":299,"properties":303},"b998a5c7-2c60-460e-a19f-a82ea9a16c79",{"id":252,"createTime":253,"updateTime":253,"relativeEntities":300,"slug":18,"properties":301,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":302},{"VI":257},{},{"title":305},{"VI":306},"H. Sprenger-Mähr",{"id":308,"sortIndex":158,"researcher":18,"roles":309,"affiliations":310,"properties":316},"2a81e507-a0d5-4aad-b6f6-adb55f4ae970",[117],[311],{"id":18,"sortIndex":19,"affiliation":312,"properties":18},{"id":261,"createTime":262,"updateTime":262,"relativeEntities":313,"slug":18,"properties":314,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":315},{"VI":266},{"title":317},{"VI":318},"M. Mündle",{"id":320,"sortIndex":19,"researcher":18,"roles":321,"affiliations":322,"properties":328},"cb714dcf-c27c-4e75-b8e7-45f8f4749957",[117],[323],{"id":18,"sortIndex":19,"affiliation":324,"properties":18},{"id":236,"createTime":237,"updateTime":237,"relativeEntities":325,"slug":18,"properties":326,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":327},{"VI":241},{"title":329},{"VI":330},"J.P. Schwaiger",{"id":332,"sortIndex":132,"researcher":18,"roles":333,"affiliations":334,"properties":340},"e285465a-d8ed-465e-9800-46d3ba8a0d10",[117],[335],{"id":18,"sortIndex":19,"affiliation":336,"properties":18},{"id":236,"createTime":237,"updateTime":237,"relativeEntities":337,"slug":18,"properties":338,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":339},{"VI":241},{"title":341},{"VI":342},"B. Kollerits",{"url":227,"publisher":344,"properties":366},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":345,"slug":10,"properties":346,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":349,"manageAffiliations":350,"indexDatabases":351,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":347,"title":348},{"VOID":13},{"EN":15},[],[],[352,359],{"id":55,"indexDatabase":353,"url":68,"indexYears":69,"academicFieldIds":358,"indexDatabaseRanking":72},{"id":57,"createTime":58,"updateTime":59,"relativeEntities":354,"label":355,"description":356,"key":65,"publicationTags":357,"standard":18},[],{"EN":62,"VI":62},{"EN":62,"VI":64},[67],[71],{"id":74,"indexDatabase":360,"url":89,"indexYears":18,"academicFieldIds":365,"indexDatabaseRanking":18},{"id":76,"createTime":77,"updateTime":78,"relativeEntities":361,"label":362,"description":363,"key":85,"publicationTags":364,"standard":18},[],{"EN":81,"VI":81},{"VI":83,"EN":84},[87,88],[91],{"volume":367,"pages":369},{"VOID":368},"70",{"VOID":370},"543-548","2006-08-01",2006,{"id":374,"createTime":375,"updateTime":376,"relativeEntities":377,"slug":378,"properties":379,"entityType":109,"verifyStatus":110,"verifyTime":376,"verifyNote":111,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":386,"fullTextUrl":18,"authors":387,"publicationType":182,"publisherRelationship":418,"citationCount":18,"citationInfo":18,"publishDate":446,"publishYear":447,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":213},"9dd6753a-7cfe-4322-8837-26c074feca6b","2024-01-25T05:32:50.266+00:00","2024-12-13T23:59:26.021+00:00",[],"The-growth-of-acute-kidney-injury-a-rising-tide-or-just-closer-attention-to-detail-",{"references":380,"title":382,"doi":384},{"VOID":381},"Marketos, 1993, Acute renal failure according to ancient Greek and Byzantine medical writers, J R Soc Med, 86, 290, 10.1177\u002F014107689308600516\nSwan, 1953, The clinical course of acute renal failure, Medicine, 32, 215, 10.1097\u002F00005792-195305000-00002\nSmith, 1964, 810\nUchino, 2005, Acute renal failure in critically ill patients: a multinational, multicenter study, Jama, 294, 813, 10.1001\u002Fjama.294.7.813\nMehta, 2004, Spectrum of acute renal failure in the intensive care unit: the PICARD experience, Kidney Int, 66, 1613, 10.1111\u002Fj.1523-1755.2004.00927.x\nXue, 2006, Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001, J Am Soc Nephrol, 17, 1135, 10.1681\u002FASN.2005060668\nWaikar, 2006, Declining mortality in patients with acute renal failure, 1988 to 2002, J Am Soc Nephrol, 17, 1143, 10.1681\u002FASN.2005091017\nHsu, 2013, Temporal Changes in Incidence of Dialysis-Requiring AKI, J Am Soc Nephrol, 24, 37, 10.1681\u002FASN.2012080800\nHsu, 2007, Community-based incidence of acute renal failure, Kidney Int, 72, 208, 10.1038\u002Fsj.ki.5002297\nSiddiqui, 2012, Secular trends in acute dialysis after elective major surgery–1995 to 2009, CMAJ, 184, 1237, 10.1503\u002Fcmaj.110895\nHsu, 2004, The incidence of end-stage renal disease is increasing faster than the prevalence of chronic renal insufficiency, Ann Intern Med, 141, 95, 10.7326\u002F0003-4819-141-2-200407200-00007\nWald, 2009, Chronic dialysis and death among survivors of acute kidney injury requiring dialysis, JAMA, 302, 1179, 10.1001\u002Fjama.2009.1322\nRicci, 2008, The RIFLE criteria and mortality in acute kidney injury: A systematic review, Kidney Int, 73, 538, 10.1038\u002Fsj.ki.5002743\nChertow, 2005, Acute kidney injury, mortality, length of stay, and costs in hospitalized patients, J Am Soc Nephrol, 16, 3365, 10.1681\u002FASN.2004090740\nCoca, 2011, Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis, Kidney Int, 81, 442, 10.1038\u002Fki.2011.379\nHsu, 2010, Where is the epidemic in kidney disease?, J Am Soc Nephrol, 21, 1607, 10.1681\u002FASN.2010050546\nSiew, 2013, The inexorable rise of AKI: can we bend the growth curve?, J Am Soc Nephrol, 24, 3, 10.1681\u002FASN.2012111115\nChawla, 2012, Acute kidney injury and chronic kidney disease: an integrated clinical syndrome, Kidney Int, 82, 516, 10.1038\u002Fki.2012.208\nLameire, 2006, The changing epidemiology of acute renal failure, Nat Clin Pract Nephrol, 2, 364, 10.1038\u002Fncpneph0218\nHwang, 2012, Validity of the International Classification of Diseases, Tenth Revision code for acute kidney injury in elderly patients at presentation to the emergency department and at hospital admission, BMJ Open, 2, 1, 10.1136\u002Fbmjopen-2012-001821\nGrams, 2014, Performance and limitations of administrative data in the identification of AKI, Clin J Am Soc Nephrol CJASN, 9, 682, 10.2215\u002FCJN.07650713\nHou, 1983, Hospital-acquired renal insufficieny: a prospective study, Am J Med, 74, 243, 10.1016\u002F0002-9343(83)90618-6\nNash, 2002, Hospital-acquired renal insufficiency, Am J Kidney Dis, 39, 930, 10.1053\u002Fajkd.2002.32766\nLevy, 1996, The effect of acute renal failure on mortality. A cohort analysis, JAMA, 275, 1489, 10.1001\u002Fjama.1996.03530430033035\nBellomo, 2004, Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group, Crit Care, 8, R204, 10.1186\u002Fcc2872\nMehta, 2007, Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury, Crit Care, 11, R31, 10.1186\u002Fcc5713\n2012, Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int Supp, 2, 19\nSiew, 2010, Commonly used surrogates for baseline renal function affect the classification and prognosis of acute kidney injury, Kidney Int, 77, 536, 10.1038\u002Fki.2009.479\nBagshaw, 2009, A comparison of observed versus estimated baseline creatinine for determination of RIFLE class in patients with acute kidney injury, Nephrol Dial Transplant, 24, 2739, 10.1093\u002Fndt\u002Fgfp159\nWaikar, 2006, Validity of International Classification of Diseases, Ninth Revision, Clinical Modification Codes for Acute Renal Failure, J Am Soc Nephrol, 17, 1688, 10.1681\u002FASN.2006010073\nMetcalfe, 2002, Acute renal failure requiring renal replacement therapy: incidence and outcome, QJM, 95, 579, 10.1093\u002Fqjmed\u002F95.9.579\nHsu, 2013, Temporal Changes in Incidence of dialysis-requiring Acute Kidney Injury, Journal of the American Society of Nephrology, 24, 37, 10.1681\u002FASN.2012080800\nRosansky, 2011, Early start of dialysis: a critical review, Clin J Am Soc Nephrol, 6, 1222, 10.2215\u002FCJN.09301010\nRosansky, 2011, Early start of hemodialysis may be harmful, Arch Intern Med, 171, 396, 10.1001\u002Farchinternmed.2010.415\nLiu, 2006, Timing of initiation of dialysis in critically ill patients with acute kidney injury, Clin J Am Soc Nephrol, 1, 915, 10.2215\u002FCJN.01430406\nShiao, 2009, Late initiation of renal replacement therapy is associated with worse outcomes in acute kidney injury after major abdominal surgery, Crit Care, 13, R171, 10.1186\u002Fcc8147\nThakar, 2012, Timing of dialysis initiation in AKI in ICU: international survey, Crit Care, 16, R237, 10.1186\u002Fcc11906\nClark, 2012, Timing of initiation of renal replacement therapy for acute kidney injury: a survey of nephrologists and intensivists in Canada, Nephrol Dial Transplant, 27, 2761, 10.1093\u002Fndt\u002Fgfr740\nWiedemann, 2006, Comparison of two fluid-management strategies in acute lung injury, N Engl J Med, 354, 2564, 10.1056\u002FNEJMoa062200\nLiu, 2011, Acute kidney injury in patients with acute lung injury: impact of fluid accumulation on classification of acute kidney injury and associated outcomes, Crit Care Med, 39, 2665, 10.1097\u002FCCM.0b013e318228234b\nGrams, 2011, Fluid balance, diuretic use, and mortality in acute kidney injury, Clin J Am Soc Nephrol, 6, 966, 10.2215\u002FCJN.08781010\nButcher, 2012, Fluid overload in AKI: epiphenomenon or putative effect on mortality?, Curr Opin Crit Care, 18, 593, 10.1097\u002FMCC.0b013e32835a1c44\nGrams, 2010, Albuminuria and estimated glomerular filtration rate independently associate with acute kidney injury, J Am Soc Nephrol, 21, 1757, 10.1681\u002FASN.2010010128\nHsu, 2008, The risk of acute renal failure in patients with chronic kidney disease, Kidney Int, 74, 101, 10.1038\u002Fki.2008.107\nCoresh, 2003, Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey, Am J Kidney Dis, 41, 1, 10.1053\u002Fajkd.2003.50007\nCoresh, 1995, Survival on dialysis among chronic renal failure patients treated with a supplemented low-protein diet before dialysis, J Am Soc Nephrol, 6, 1379, 10.1681\u002FASN.V651379\nSiddiqui, 2012, Secular trends in acute dialysis after elective major surgery–1995 to 2009, CMAJ, 184, 1237, 10.1503\u002Fcmaj.110895\nWinkelmayer, 2005, Identification of individuals with CKD from Medicare claims data: a validation study, Am J Kidney Dis, 46, 225, 10.1053\u002Fj.ajkd.2005.04.029\nFleet, 2013, Detecting chronic kidney disease in population-based administrative databases using an algorithm of hospital encounter and physician claim codes, BMC Nephrol, 14, 81, 10.1186\u002F1471-2369-14-81\nKern, 2006, Failure of ICD-9-CM codes to identify patients with comorbid chronic kidney disease in diabetes, Health Serv Res, 41, 564, 10.1111\u002Fj.1475-6773.2005.00482.x\nOwan, 2006, Secular trends in renal dysfunction and outcomes in hospitalized heart failure patients, J Card Fail, 12, 257, 10.1016\u002Fj.cardfail.2006.02.007\nWriting Group Members Lloyd-Jones, 2010, Heart disease and stroke statistics–2010 update: a report from the American Heart Association, Circulation, 121, e46, 10.1161\u002FCIRCULATIONAHA.109.192667\nAdams, 2008, Clinical predictors of in-hospital mortality in acutely decompensated heart failure-piecing together the outcome puzzle, Congest Heart Fail, 14, 127, 10.1111\u002Fj.1751-7133.2008.04641.x\nGrams, 2010, Albuminuria and estimated glomerular filtration rate independently associate with acute kidney injury, J Am Soc Nephrol, 21, 1757, 10.1681\u002FASN.2010010128\nJames, 2010, Glomerular filtration rate, proteinuria, and the incidence and consequences of acute kidney injury: a cohort study, Lancet, 376, 2096, 10.1016\u002FS0140-6736(10)61271-8\nHsu, 2011, Proteinuria and reduced glomerular filtration rate as risk factors for acute kidney injury, Curr Opin Nephrol Hypertens, 20, 211, 10.1097\u002FMNH.0b013e3283454f8d\nFraze, 2010, Hospital Stays for Patients with Diabetes, 2008 (Statistical Brief #93)\nBillings, 2012, Obesity and oxidative stress predict AKI after cardiac surgery, J Am Soc Nephrol, 23, 1221, 10.1681\u002FASN.2011090940\nPatil, 2012, Prevalence of grade II and III obesity among patients hospitalized with cardiovascular diagnoses in 2002 v. 2009, Mo Med, 109, 397\nNagamine, 2006, Trends in elderly Hospitalizations, 1997-2004\nRubenfeld, 2005, Incidence and outcomes of acute lung injury, N Eng J Med, 353, 1685, 10.1056\u002FNEJMoa050333\nMartin, 2006, The effect of age on the development and outcome of adult sepsis, Crit Care Med, 34, 15, 10.1097\u002F01.CCM.0000194535.82812.BA\nAnderson, 2011, Acute kidney injury in older adults, J Am Soc Nephrol, 22, 28, 10.1681\u002FASN.2010090934\nSeymour, 2012, Severe sepsis in pre-hospital emergency care: analysis of incidence, care, and outcome, Am J Respir Crit Care Med, 186, 1264, 10.1164\u002Frccm.201204-0713OC\nMartin, 2003, The epidemiology of sepsis in the United States from 1979 through 2000, N Engl J Med, 348, 1546, 10.1056\u002FNEJMoa022139\nDombrovskiy, 2007, Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003, Crit Care Med, 35, 1244, 10.1097\u002F01.CCM.0000261890.41311.E9\nFry, 2005, Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988-2002, JAMA, 294, 2712, 10.1001\u002Fjama.294.21.2712\nHeywood, 2007, High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database, J Card Fail, 13, 422, 10.1016\u002Fj.cardfail.2007.03.011\nFonarow, 2005, Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis, JAMA, 293, 572, 10.1001\u002Fjama.293.5.572\nForman, 2004, Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure, J Am Coll Cardiol, 43, 61, 10.1016\u002Fj.jacc.2003.07.031\nLogeart, 2008, Transient worsening of renal function during hospitalization for acute heart failure alters outcome, Int J Cardiol, 127, 228, 10.1016\u002Fj.ijcard.2007.06.007\nHassan, 2010, Increasing rates of angioplasty versus bypass surgery in Canada, 1994-2005, Am Heart J, 160, 958, 10.1016\u002Fj.ahj.2010.06.052\nAmin, 2012, Trends in the incidence of acute kidney injury in patients hospitalized with acute myocardial infarction, Arch Intern Med, 172, 246, 10.1001\u002Farchinternmed.2011.1202\nNeilson, 2004, The impact of peer management on test-ordering behavior, Ann Intern Med, 141, 196, 10.7326\u002F0003-4819-141-3-200408030-00008\nLenihan, 2013, Trends in acute kidney injury, associated use of dialysis, and mortality after cardiac surgery, 1999 to 2008, Ann Thorac Surg, 95, 20, 10.1016\u002Fj.athoracsur.2012.05.131\nSerruys, 2009, Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease, N Engl J Med, 360, 961, 10.1056\u002FNEJMoa0804626\nFarkouh, 2012, Strategies for multivessel revascularization in patients with diabetes, N Engl J Med, 367, 2375, 10.1056\u002FNEJMoa1211585\nSalahudeen, 2013, Onconephrology: the latest frontier in the war against kidney disease, J Am Soc Nephrol, 24, 26, 10.1681\u002FASN.2012070690\nLam, 2012, Onco-nephrology: AKI in the cancer patient, Clin J Am Soc Nephrol, 7, 1692, 10.2215\u002FCJN.03140312\nPerazella, 2014, Cancer and the kidney: the growth of onco-nephrology, Adv Chronic Kidney Dis, 21, 4, 10.1053\u002Fj.ackd.2013.09.002\nSiegel, 2014, Cancer Statistics, 2014, CA Cancer J Clin, 64, 9, 10.3322\u002Fcaac.21208\nSalahudeen, 2013, Incidence rate, clinical correlates, and outcomes of AKI in patients admitted to a comprehensive cancer center, Clin J Am Soc Nephrol, 8, 347, 10.2215\u002FCJN.03530412\nPerazella, 2012, Onco-nephrology: renal toxicities of chemotherapeutic agents, Clin J Am Soc Nephrol, 7, 1713, 10.2215\u002FCJN.02780312\nUchino, 2006, The epidemiology of acute renal failure in the world, Curr Opin Crit Care, 12, 538, 10.1097\u002F01.ccx.0000247448.94252.5a\nHui-Stickle, 2005, Pediatric ARF epidemiology at a tertiary care center from 1999 to 2001, Am J Kidney Dis, 45, 96, 10.1053\u002Fj.ajkd.2004.09.028\nMoffett, 2011, Acute kidney injury and increasing nephrotoxic-medication exposure in noncritically-ill children, Clin J Am Soc Nephrol, 6, 856, 10.2215\u002FCJN.08110910\nPerazella, 2012, Drug use and nephrotoxicity in the intensive care unit, Kidney Int, 81, 1172, 10.1038\u002Fki.2010.475\nMyburgh, 2012, Hydroxyethyl starch or saline for fluid resuscitation in intensive care, N Engl J Med, 367, 1901, 10.1056\u002FNEJMoa1209759\nPerner, 2012, Hydroxyethyl starch 130\u002F0.42 versus Ringer’s acetate in severe sepsis, N Engl J Med, 367, 124, 10.1056\u002FNEJMoa1204242\nZarychanski, 2013, Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis, JAMA, 309, 678, 10.1001\u002Fjama.2013.430\nYunos, 2012, Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults, JAMA, 308, 1566, 10.1001\u002Fjama.2012.13356\nKellum, 2013, for the KAKIGWG. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1), Crit Care, 17, 204, 10.1186\u002Fcc11454\nPalevsky, 2013, KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury, Am J Kidney Dis, 61, 649, 10.1053\u002Fj.ajkd.2013.02.349\nRivers, 2001, Early goal-directed therapy in the treatment of severe sepsis and septic shock, N Engl J Med, 345, 1368, 10.1056\u002FNEJMoa010307\nLevy, 2010, The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis, Intensive Care Med, 36, 222, 10.1007\u002Fs00134-009-1738-3\nWilliams, 2012, Critical and honest conversations: the evidence behind the ‘Choosing Wisely’ campaign recommendations by the American Society of Nephrology, Clin J Am Soc Nephrol, 7, 1664, 10.2215\u002FCJN.04970512\nPlantinga, 2011, Nonsteroidal anti-inflammatory drug use among persons with chronic kidney disease in the United States, Ann Family Med, 9, 423, 10.1370\u002Fafm.1302\nPeralta, 2007, Association of antihypertensive therapy and diastolic hypotension in chronic kidney disease, Hypertension, 50, 474, 10.1161\u002FHYPERTENSIONAHA.107.088088\nAbuelo, 2007, Normotensive ischemic acute renal failure, N Engl J Med, 357, 797, 10.1056\u002FNEJMra064398\nLewis, 1993, The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group, N Engl J Med, 329, 1456, 10.1056\u002FNEJM199311113292004\nKramer, 1997, Ramipril in non-diabetic renal failure (REIN study). Ramipril Efficiency in Nephropathy study, Lancet, 350, 736, 10.1016\u002FS0140-6736(97)26036-8\nLewis, 2001, Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes, N Engl J Med, 345, 851, 10.1056\u002FNEJMoa011303\nYusuf, 2000, Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators, N Engl J Med, 342, 145, 10.1056\u002FNEJM200001203420301\nChobanian, 2003, The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report, JAMA, 289, 2560, 10.1001\u002Fjama.289.19.2560\nKDOQI, 2007, KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease, Am J Kidney Dis, 49, S12, 10.1053\u002Fj.ajkd.2006.12.005\nNational Kidney Foundation, 2002, K\u002FDOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification, Am J Kidney Dis, 39, S1\nLevey, 2005, Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO), Kidney Int, 67, 2089, 10.1111\u002Fj.1523-1755.2005.00365.x\nJain, 2012, Reporting of the estimated glomerular filtration rate was associated with increased use of angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers in CKD, Kidney Int, 81, 1248, 10.1038\u002Fki.2012.18\nCox, 2013, Adverse drug events during AKI and its recovery, Clin J Am Soc Nephrol, 8, 1070, 10.2215\u002FCJN.11921112\nArora, 2008, Preoperative use of angiotensin-converting enzyme inhibitors\u002Fangiotensin receptor blockers is associated with increased risk for acute kidney injury after cardiovascular surgery, Clin J Am Soc Nephrol, 3, 1266, 10.2215\u002FCJN.05271107\nRim, 2012, The effect of renin-angiotensin-aldosterone system blockade on contrast-induced acute kidney injury: a propensity-matched study, Am J Kidney Dis, 60, 576, 10.1053\u002Fj.ajkd.2012.04.017\nMann, 2008, Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial, Lancet, 372, 547, 10.1016\u002FS0140-6736(08)61236-2\nFried, 2013, Combined Angiotensin inhibition for the treatment of diabetic nephropathy, N Engl J Med, 369, 1892, 10.1056\u002FNEJMoa1303154\nLapi, 2013, Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study, BMJ, 346, e8525, 10.1136\u002Fbmj.e8525\nOkusa, 2013, Reading between the guidelines - The KIDGO Practice Guideline on acute kidney injury in the individual patient, Kidney Int, 85, 39, 10.1038\u002Fki.2013.378\nDavenport, 2011, Pitfalls in assessing renal function in patients with cirrhosis–potential inequity for access to treatment of hepatorenal failure and liver transplantation, Nephrol Dial Transplant, 26, 2735, 10.1093\u002Fndt\u002Fgfr354\nMacedo, 2010, Fluid accumulation, recognition and staging of acute kidney injury in critically-ill patients, Crit Care, 14, R82, 10.1186\u002Fcc9004\nCoca, 2013, Preoperative angiotensin-converting enzyme inhibitors and angiotensin receptor blocker use and acute kidney injury in patients undergoing cardiac surgery, Nephrol Dial Transplant, 28, 2787, 10.1093\u002Fndt\u002Fgft405\nTestani, 2010, Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival, Circulation, 122, 265, 10.1161\u002FCIRCULATIONAHA.109.933275\nTestani, 2013, Timing of hemoconcentration during treatment of acute decompensated heart failure and subsequent survival: importance of sustained decongestion, J Am Coll Cardiol, 62, 516, 10.1016\u002Fj.jacc.2013.05.027\nMurray, 2014, Current use of biomarkers in acute kidney injury: report and summary of recommendations from the 10th Acute Dialysis Quality Initiative consensus conference, Kidney Int, 85, 513, 10.1038\u002Fki.2013.374\nMcCullough, 2013, Implementation of novel biomarkers in the diagnosis, prognosis, and management of acute kidney injury: executive summary from the Tenth Consensus Conference of the Acute Dialysis Quality Initiative (ADQI), Contrib Nephrol, 182, 5, 10.1159\u002F000349962\nMcCullough, 2013, Diagnosis of acute kidney injury using functional and injury biomarkers: workgroup statements from the tenth acute dialysis quality initiative consensus conference, Contrib Nephrol, 182, 13, 10.1159\u002F000349963\nCoca, 2014, Urinary biomarkers of AKI and mortality 3 years after cardiac surgery, J Am Soc Nephrol, 25, 1063, 10.1681\u002FASN.2013070742\nHaase, 2011, The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies, J Am Coll Cardiol, 57, 1752, 10.1016\u002Fj.jacc.2010.11.051\nBelcher, 2014, Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury, Hepatology, 60, 622, 10.1002\u002Fhep.26980\nHsu, 2013, Regional variation in the incidence of dialysis-requiring AKI in the United States, Clin J Am Soc Nephrol, 8, 1476, 10.2215\u002FCJN.12611212\nSiew, 2012, Estimating baseline kidney function in hospitalized patients with impaired kidney function, Clin J Am Soc Nephrol, 7, 712, 10.2215\u002FCJN.10821011\nSiew, 2013, Use of multiple imputation method to improve estimation of missing baseline serum creatinine in acute kidney injury research, Clin J Am Soc Nephrol, 8, 10, 10.2215\u002FCJN.00200112\nThakar, 2009, Incidence and outcomes of acute kidney injury in intensive care units: a Veterans Administration study, Crit Care Med, 37, 2552, 10.1097\u002FCCM.0b013e3181a5906f\nJoannidis, 2009, Acute kidney injury in critically ill patients classified by AKIN versus RIFLE using the SAPS 3 database, Intensive Care Med, 35, 1692, 10.1007\u002Fs00134-009-1530-4\nAlpert, 2006, A call for universal definitions in cardiovascular disease, Circulation, 114, 757, 10.1161\u002FCIRCULATIONAHA.106.648030\nThygesen, 2012, Third universal definition of myocardial infarction, J Am Coll Cardiol, 60, 1581, 10.1016\u002Fj.jacc.2012.08.001\nChertow, 1998, Independent association between acute renal failure and mortality following cardiac surgery, Am J Med, 104, 343, 10.1016\u002FS0002-9343(98)00058-8\nMangano, 1998, Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group, Ann Intern Med, 128, 194, 10.7326\u002F0003-4819-128-3-199802010-00005\nHobson, 2009, Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery, Circulation, 119, 2444, 10.1161\u002FCIRCULATIONAHA.108.800011\nDasta, 2008, Costs and outcomes of acute kidney injury (AKI) following cardiac surgery, Nephrol Dial Transplant, 23, 1970, 10.1093\u002Fndt\u002Fgfm908\nKuitunen, 2006, Acute renal failure after cardiac surgery: evaluation of the RIFLE classification, Ann Thorac Surg, 81, 542, 10.1016\u002Fj.athoracsur.2005.07.047\nLiangos, 2006, Epidemiology and outcomes of acute renal failure in hospitalized patients: a national survey, Clin J Am Soc Nephrol, 1, 43, 10.2215\u002FCJN.00220605\nUchino, 2006, An assessment of the RIFLE criteria for acute renal failure in hospitalized patients, Crit Care Med, 34, 1913, 10.1097\u002F01.CCM.0000224227.70642.4F\nAli, 2007, Incidence and outcomes in acute kidney injury: a comprehensive population-based study, J Am Soc Nephrol, 18, 1292, 10.1681\u002FASN.2006070756\nPorter, 2014, A real-time electronic alert to improve detection of acute kidney injury in a large teaching hospital\nBrivet, 1996, Acute renal failure in intensive care units–causes, outcome, and prognostic factors of hospital mortality; a prospective, multicenter study. French Study Group on Acute Renal Failure, Crit Care Med, 24, 192, 10.1097\u002F00003246-199602000-00003\nHoste, 2006, RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis, Crit Care, 10, R73, 10.1186\u002Fcc4915\nOstermann, 2007, Acute kidney injury in the intensive care unit according to RIFLE, Crit Care Med, 35, 1837, 10.1097\u002F01.CCM.0000277041.13090.0A\nBagshaw, 2008, A multi-centre evaluation of the RIFLE criteria for early acute kidney injury in critically ill patients, Nephrol Dial Transplant, 23, 1203, 10.1093\u002Fndt\u002Fgfm744\nBagshaw, 2008, A comparison of the RIFLE and AKIN criteria for acute kidney injury in critically ill patients, Nephrol Dial Transplant, 23, 1569, 10.1093\u002Fndt\u002Fgfn009\nBagshaw, 2008, Early acute kidney injury and sepsis: a multicentre evaluation, Crit Care, 12, R47, 10.1186\u002Fcc6863\nCruz, 2007, North East Italian Prospective Hospital Renal Outcome Survey on Acute Kidney Injury (NEiPHROS-AKI): targeting the problem with the RIFLE Criteria, Clin J Am Soc Nephrol, 2, 418, 10.2215\u002FCJN.03361006\nNisula, 2013, Incidence, risk factors and 90-day mortality of patients with acute kidney injury in Finnish intensive care units: the FINNAKI study, Intensive Care Med, 39, 420, 10.1007\u002Fs00134-012-2796-5\nFeest, 1993, Incidence of severe acute renal failure in adults: results of a community based study, BMJ, 306, 481, 10.1136\u002Fbmj.306.6876.481\nKhan, 1997, Acute renal failure: factors influencing nephrology referral and outcome, QJM, 90, 781, 10.1093\u002Fqjmed\u002F90.12.781\nLiano, 1996, Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Madrid Acute Renal Failure Study Group, Kidney Int, 50, 811, 10.1038\u002Fki.1996.380\nKorkeila, 2000, Costs of care, long-term prognosis and quality of life in patients requiring renal replacement therapy during intensive care, Intensive Care Med, 26, 1824, 10.1007\u002Fs001340000726\nStevens, 2001, Non-specialist management of acute renal failure, QJM, 94, 533, 10.1093\u002Fqjmed\u002F94.10.533\nCole, 2000, A prospective, multicenter study of the epidemiology, management, and outcome of severe acute renal failure in a ‘closed’ ICU system, Am J Respir Crit Care Med, 162, 191, 10.1164\u002Fajrccm.162.1.9907016\nRobertson, 2002, High incidence of renal failure requiring short-term dialysis: a prospective observational study, QJM, 95, 585, 10.1093\u002Fqjmed\u002F95.9.585\nPrescott, 2007, A prospective national study of acute renal failure treated with RRT: incidence, aetiology and outcomes, Nephrol Dial Transplant, 22, 2513, 10.1093\u002Fndt\u002Fgfm264\nParsons, 1961, Optimal conditions for methacrylate embedding of certain tissues and cells sensitive to polymerization damage, Exp Cell Res, 24, 466, 10.1016\u002F0014-4827(61)90447-5\nFischer, 1966, Early dialysis in the treatment of acute renal failure, Surg Gynecol Obstet, 123, 1019\nKleinknecht, 1972, Uremic and non-uremic complications in acute renal failure: evaluation of early and frequent dialysis on prognosis, Kidney Int, 1, 190, 10.1038\u002Fki.1972.26\nGettings, 1999, Outcome in post-traumatic acute renal failure when continuous renal replacement therapy is applied early vs. late, Intensive Care Med, 25, 805, 10.1007\u002Fs001340050956\nMehta, 2001, A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure, Kidney Int, 60, 1154, 10.1046\u002Fj.1523-1755.2001.0600031154.x\nSchiffl, 2002, Daily hemodialysis and the outcome of acute renal failure, N Engl J Med, 346, 305, 10.1056\u002FNEJMoa010877\nRonco, 2000, Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial, Lancet, 356, 26, 10.1016\u002FS0140-6736(00)02430-2\nBouman, 2002, Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial, Critical Care Med, 30, 2205, 10.1097\u002F00003246-200210000-00005\nCho, 2006, Survival by dialysis modality in critically ill patients with acute kidney injury, J Am Soc Nephrol, 17, 3132, 10.1681\u002FASN.2006030268\nVinsonneau, 2006, Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial, Lancet, 368, 379, 10.1016\u002FS0140-6736(06)69111-3\nUchino, 2007, Continuous renal replacement therapy: a worldwide practice survey: The Beginning and Ending Supportive Therapy for the Kidney (B.E.S.T. Kidney) Investigators, Intensive Care Med, 33, 1563, 10.1007\u002Fs00134-007-0754-4\nCarl, 2010, Effect of timing of dialysis on mortality in critically ill, septic patients with acute renal failure, Hemodial Int, 14, 11, 10.1111\u002Fj.1542-4758.2009.00407.x\nPrescott, 2007, A prospective national study of acute renal failure treated with RRT: incidence, aetiology and outcomes, Nephrol Dial Transplant, 22, 2513, 10.1093\u002Fndt\u002Fgfm264\nPalevsky, 2008, Intensity of renal support in critically ill patients with acute kidney injury, N Engl J Med, 359, 7, 10.1056\u002FNEJMoa0802639\nBellomo, 2009, Intensity of continuous renal-replacement therapy in critically ill patients, N Engl J Med, 361, 1627, 10.1056\u002FNEJMoa0902413\nLeonard, 2012, Proton pump inhibitors and traditional nonsteroidal anti-inflammatory drugs and the risk of acute interstitial nephritis and acute kidney injury, Pharmacoepidemiol Drug Saf, 21, 1155, 10.1002\u002Fpds.3329\nDormuth, 2013, Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases, BMJ, 346, f880, 10.1136\u002Fbmj.f880\nBird, 2013, Risk of acute kidney injury associated with the use of fluoroquinolones, CMAJ, 185, E475, 10.1503\u002Fcmaj.121730\nHurst, 2007, Association of oral sodium phosphate purgative use with acute kidney injury, J Am Soc Nephrol, 18, 3192, 10.1681\u002FASN.2007030349\nZhao, 2012, New fibrate use and acute renal outcomes in elderly adults: a population-based study, Ann Intern Med, 156, 560, 10.7326\u002F0003-4819-156-8-201204170-00401\nSchneider, 2006, Association of selective and conventional nonsteroidal antiinflammatory drugs with acute renal failure: a population-based, nested case-control analysis, Am J Epidemiol, 164, 881, 10.1093\u002Faje\u002Fkwj331\nWikman, 2013, The significance of antiretroviral-associated acute kidney injury in a cohort of ambulatory human immunodeficiency virus-infected patients, Nephrol Dial Transplant, 28, 2073, 10.1093\u002Fndt\u002Fgft210\nGandhi, 2013, Calcium-channel blocker-clarithromycin drug interactions and acute kidney injury, JAMA, 310, 2544, 10.1001\u002Fjama.2013.282426",{"EN":383},"The growth of acute kidney injury: a rising tide or just closer attention to detail?",{"VOID":385},"10.1038\u002Fki.2014.293","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0085253815300272",[388,403],{"id":389,"sortIndex":171,"researcher":18,"roles":390,"affiliations":391,"properties":400},"d907d633-6bcc-4308-8501-eadbf46229b7",[117],[392],{"id":18,"sortIndex":19,"affiliation":393,"properties":18},{"id":394,"createTime":395,"updateTime":395,"relativeEntities":396,"slug":18,"properties":397,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"2383d2c9-8f84-4bae-92b8-4241c4fc0dcb","2024-01-15T05:55:07.457+00:00",[],{"title":398},{"VI":399},"UCL Center for Nephrology, Royal Free Hospital, University College London Medical School, London, UK",{"title":401},{"VI":402},"Andrew Davenport",{"id":404,"sortIndex":19,"researcher":18,"roles":405,"affiliations":406,"properties":415},"4306e14e-0406-43ca-9fd6-fd5bf21c5930",[117],[407],{"id":18,"sortIndex":19,"affiliation":408,"properties":18},{"id":409,"createTime":410,"updateTime":410,"relativeEntities":411,"slug":18,"properties":412,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"7b055611-e35c-4c71-956f-111b4a392982","2024-01-08T05:20:06.197+00:00",[],{"title":413},{"VI":414},"Division of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, Tennessee, USA",{"title":416},{"VI":417},"Edward D. Siew",{"url":386,"publisher":419,"properties":441},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":420,"slug":10,"properties":421,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":424,"manageAffiliations":425,"indexDatabases":426,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":422,"title":423},{"VOID":13},{"EN":15},[],[],[427,434],{"id":55,"indexDatabase":428,"url":68,"indexYears":69,"academicFieldIds":433,"indexDatabaseRanking":72},{"id":57,"createTime":58,"updateTime":59,"relativeEntities":429,"label":430,"description":431,"key":65,"publicationTags":432,"standard":18},[],{"EN":62,"VI":62},{"EN":62,"VI":64},[67],[71],{"id":74,"indexDatabase":435,"url":89,"indexYears":18,"academicFieldIds":440,"indexDatabaseRanking":18},{"id":76,"createTime":77,"updateTime":78,"relativeEntities":436,"label":437,"description":438,"key":85,"publicationTags":439,"standard":18},[],{"EN":81,"VI":81},{"VI":83,"EN":84},[87,88],[91],{"volume":442,"pages":444},{"VOID":443},"87",{"VOID":445},"46-61","2015-01-01",2015,{"id":449,"createTime":450,"updateTime":451,"relativeEntities":452,"slug":453,"properties":454,"entityType":109,"verifyStatus":17,"verifyTime":459,"verifyNote":460,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":461,"fullTextUrl":18,"authors":462,"publicationType":182,"publisherRelationship":463,"citationCount":18,"citationInfo":18,"publishDate":493,"publishYear":494,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":213},"37292763-0128-42c9-9597-9e668bb8242a","2023-12-08T09:51:37.712+00:00","2025-01-04T23:59:12.309+00:00",[],"l-Carnitine-is-an-osmotic-agent-suitable-for-peritoneal-dialysis",{"title":455,"doi":457},{"EN":456},"l-Carnitine is an osmotic agent suitable for peritoneal dialysis",{"VOID":458},"10.1038\u002Fki.2011.117","2025-01-04T23:59:12.308+00:00","Author title is blank","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0085253815550916",[],{"url":461,"publisher":464,"properties":486},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":465,"slug":10,"properties":466,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":469,"manageAffiliations":470,"indexDatabases":471,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":467,"title":468},{"VOID":13},{"EN":15},[],[],[472,479],{"id":55,"indexDatabase":473,"url":68,"indexYears":69,"academicFieldIds":478,"indexDatabaseRanking":72},{"id":57,"createTime":58,"updateTime":59,"relativeEntities":474,"label":475,"description":476,"key":65,"publicationTags":477,"standard":18},[],{"EN":62,"VI":62},{"EN":62,"VI":64},[67],[71],{"id":74,"indexDatabase":480,"url":89,"indexYears":18,"academicFieldIds":485,"indexDatabaseRanking":18},{"id":76,"createTime":77,"updateTime":78,"relativeEntities":481,"label":482,"description":483,"key":85,"publicationTags":484,"standard":18},[],{"EN":81,"VI":81},{"VI":83,"EN":84},[87,88],[91],{"volume":487,"pages":489,"issue":491},{"VOID":488},"80",{"VOID":490},"645-654",{"VOID":492},"6","2011-09-02",2011,{"id":496,"createTime":497,"updateTime":498,"relativeEntities":499,"slug":500,"properties":501,"entityType":109,"verifyStatus":17,"verifyTime":498,"verifyNote":508,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":509,"fullTextUrl":18,"authors":510,"publicationType":182,"publisherRelationship":539,"citationCount":18,"citationInfo":18,"publishDate":567,"publishYear":568,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":213},"509d5019-86cd-4456-9b70-dc063333a720","2023-12-13T17:18:51.770+00:00","2025-01-14T23:58:39.871+00:00",[],"Mutagenesis-of-the-epithelial-polarity-gene-discs-large-1-perturbs-nephrogenesis-in-the-developing-mouse-kidney",{"references":502,"title":504,"doi":506},{"VOID":503},"Saxen, 1987, Early organogenesis of the kidney, Pediatr Nephrol, 1, 385, 10.1007\u002FBF00849241\nClark, 1999, Molecular regulation of nephron endowment, Am J Physiol, 276, F485\nHorster, 1999, Embryonic renal epithelia: induction, nephrogenesis, and cell differentiation, Physiol Rev, 79, 1157, 10.1152\u002Fphysrev.1999.79.4.1157\nLee, 2002, A novel and conserved protein-protein interaction domain of mammalian Lin-2\u002FCASK binds and recruits SAP97 to the lateral surface of epithelia, Mol Cell Biol, 22, 1778, 10.1128\u002FMCB.22.6.1778-1791.2002\nAnderson, 1996, Cell signalling: MAGUK magic, Curr Biol, 6, 382, 10.1016\u002FS0960-9822(02)00501-8\nDimitratos, 1999, Signalling pathways are focussed at specialized regions of the plasma membrane by scaffolding proteins of the MAGUK family, Bioessays, 21, 912, 10.1002\u002F(SICI)1521-1878(199911)21:11\u003C912::AID-BIES3>3.0.CO;2-Z\nCaruana, 2002, Genetic studies define MAGUK proteins as regulators of epithelial cell polarity, Int J Dev Biol, 46, 511\nGonzalez-mariscal, 2000, Tight junction proteins ZO-1, ZO-2, and occludin along isolated renal tubules, Kidney Int, 57, 2386, 10.1046\u002Fj.1523-1755.2000.00098.x\nKaech, 1998, The LIN-2\u002FLIN-7\u002FLIN-10 complex mediates basolateral membrane localization of the C. elegans EGF receptor LET-23 in vulval epithelial cells, Cell, 94, 761, 10.1016\u002FS0092-8674(00)81735-3\nStewart, 1972, The recovery and preliminary characterization of X chromosome mutants affecting imaginal discs of Drosophila melanogaster, Dev Biol, 27, 71, 10.1016\u002F0012-1606(72)90113-3\nWoods, 1996, Dlg protein is required for junction structure, cell polarity, and proliferation control in Drosophila epithelia, J Cell Biol, 134, 1469, 10.1083\u002Fjcb.134.6.1469\nWoods, 1989, Molecular cloning of the lethal (1) discs large-1 oncogene of Drosophila, Dev Biol, 134, 222, 10.1016\u002F0012-1606(89)90092-4\nCaruana, 2001, Craniofacial dysmorphogenesis including cleft palate in mice with an insertional mutation in the discs large gene, Mol Cell Biol, 21, 1475, 10.1128\u002FMCB.21.5.1475-1483.2001\nNguyen, 2003, Requirement of PDZ-containing proteins for cell cycle regulation and differentiation in the mouse lens epithelium, Mol Cell Biol, 23, 8970, 10.1128\u002FMCB.23.24.8970-8981.2003\nStanford, 1998, Expression trapping: Identification of novel genes expressed in hematopoietic and endothelial lineages by gene trapping in ES cells, Blood, 92, 4622, 10.1182\u002Fblood.V92.12.4622\nClark, 2001, In vitro studies on the roles of transforming growth factor-β1 in rat metanephric development, Kidney Int, 59, 1641, 10.1046\u002Fj.1523-1755.2001.0590051641.x\nMartinez, 2002, BMPs and BMP receptors in mouse metanephric development: in vivo and in vitro studies, Int J Dev Biol, 46, 525\nCullen, 2000, Studies on the effects of gentamicin on rat metanephric development in vitro, Nephrology, 5, 115, 10.1046\u002Fj.1440-1797.2000.00512.x\nPichel, 1996, GDNF is required for kidney development and enteric innervation, Cold Spring Harbor Symp Quant Biol, 61, 445, 10.1101\u002FSQB.1996.061.01.047\nClark, 2004, Rescue of defective branching morphogenesis in renal-coloboma syndrome by the caspase inhibitor, Z-VAD-fmk, J Am Soc Nephrol, 15, 299, 10.1097\u002F01.ASN.0000111248.23454.19\nZhao, 2004, Role of fibroblast growth factor receptors 1 and 2 in the ureteric bud, Dev Biol, 276, 403, 10.1016\u002Fj.ydbio.2004.09.002\nSariola, 2002, Nephron induction revisited: from caps to condensates, Curr Opin Nephrol Hypertens, 11, 17, 10.1097\u002F00041552-200201000-00003\nReuver, 1998, E-cadherin mediated cell adhesion recruits SAP97 into the cortical cytoskeleton, J Cell Sci, 111, 1071, 10.1242\u002Fjcs.111.8.1071\nKlocker, 2002, Synaptic glutamate receptor clustering in mice lacking the SH3 and GK domains of SAP97, Eur J Neurosci, 16, 1517, 10.1046\u002Fj.1460-9568.2002.02228.x\nBoller, 1985, Cell-adhesion molecule uvomorulin is localized in the intermediate junctions of adult intestinal epithelial cells, J Cell Biol, 100, 327, 10.1083\u002Fjcb.100.1.327\nMandai, 1997, Afadin: A novel actin filament-binding protein with one PDZ domain localized at cadherin-based cell-to-cell adherens junction, J Cell Biol, 139, 517, 10.1083\u002Fjcb.139.2.517\nMandai, 1999, Ponsin\u002FSH3P12: An l-Afadin- and vinculin-binding protein localized at cell-cell and cell-matrix adherens junctions, J Cell Biol, 144, 1001, 10.1083\u002Fjcb.144.5.1001\nLaprise, 2004, Human homolog of disc-large is required for adherens junction assembly and differentiation of human intestinal epithelial cells, J Biol Chem, 279, 10157, 10.1074\u002Fjbc.M309843200\nFirestein, 2001, DLG-1 is a MAGUK similar to SAP97 and is required for adherens junction formation, Mol Biol Cell, 12, 3465, 10.1091\u002Fmbc.12.11.3465\nHough, 1997, Organizing a functional junctional complex requires specific domains of the Drosophila MAGUK Discs large, Genes Dev, 11, 3242, 10.1101\u002Fgad.11.23.3242\nWu, 1998, Subcellular targeting and cytoskeletal attachment of SAP97 to the epithelial lateral membrane, J Cell Sci, 111, 2365, 10.1242\u002Fjcs.111.16.2365\nMcgee, 1999, Identification of an intramolecular interaction between the SH3 and guanylate kinase domains of PSD-95, J Biol Chem, 274, 17431, 10.1074\u002Fjbc.274.25.17431\nWu, 2000, Intramolecular interactions regulate SAP97 binding to GKAP, EMBO J, 19, 5740, 10.1093\u002Femboj\u002F19.21.5740\nNix, 2000, hCASK and hDlg associate in epithelia, and their src homology 3 and guanylate kinase domains participate in both intramolecular and intermolecular interactions, J Biol Chem, 275, 41192, 10.1074\u002Fjbc.M002078200\nShin, 2000, An intramolecular interaction between Src homology 3 domain and guanylate kinase-like domain required for channel clustering by postsynaptic density-95\u002FSAP90, J Neurosci, 20, 3580, 10.1523\u002FJNEUROSCI.20-10-03580.2000\nStraight, 2000, mLin-7 is localized to the basolateral surface of renal epithelia via its NH(2) terminus, Am J Physiol Renal Physiol, 278, F464, 10.1152\u002Fajprenal.2000.278.3.F464\nCullen-mcewen, 2001, Nephron endowment in glial cell line-derived neurotrophic factor (GDNF) heterozygous mice, Kidney Int, 60, 31, 10.1046\u002Fj.1523-1755.2001.00767.x\nSchuchardt, 1996, Renal agenesis and hypoplasia in ret-k mutant mice result from defects in ureteric bud development, Development, 122, 1919, 10.1242\u002Fdev.122.6.1919\nDziarmaga, 2003, Ureteric bud apoptosis and renal hypoplasia in transgenic PAX2-Bax fetal mice mimics the renal-coloboma syndrome, J Am Soc Nephrol, 14, 2767, 10.1097\u002F01.ASN.0000094082.11026.EE\nPichel, 1996, Defects in enteric innervation and kidney development in mice lacking GDNF, Nature, 382, 73, 10.1038\u002F382073a0\nMah, 2000, Kidney development in cadherin-6 mutants: delayed mesenchyme-to-epithelial conversion and loss of nephrons, Dev Biol, 223, 38, 10.1006\u002Fdbio.2000.9738",{"EN":505},"Mutagenesis of the epithelial polarity gene, discs large 1, perturbs nephrogenesis in the developing mouse kidney",{"VOID":507},"10.1111\u002Fj.1523-1755.2005.00489.x","Author affiliation is blank","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS008525381550923X",[511,518,525,532],{"id":512,"sortIndex":19,"researcher":18,"roles":513,"affiliations":514,"properties":515},"8b083ccf-1495-49e3-a91a-fed82de301e2",[117],[],{"title":516},{"VI":517},"Eman Naim",{"id":519,"sortIndex":132,"researcher":18,"roles":520,"affiliations":521,"properties":522},"bf6cefd1-6ad3-4fe0-85b6-58137c547fdf",[117],[],{"title":523},{"VI":524},"Georgina Caruana",{"id":526,"sortIndex":171,"researcher":18,"roles":527,"affiliations":528,"properties":529},"3a47f0f2-908b-4d27-a4dc-4654c8058722",[117],[],{"title":530},{"VI":531},"Alan Bernstein",{"id":533,"sortIndex":145,"researcher":18,"roles":534,"affiliations":535,"properties":536},"1c38af27-c399-49d2-ac9d-194722d9d840",[117],[],{"title":537},{"VI":538},"John F. Bertram",{"url":509,"publisher":540,"properties":562},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":541,"slug":10,"properties":542,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":545,"manageAffiliations":546,"indexDatabases":547,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":543,"title":544},{"VOID":13},{"EN":15},[],[],[548,555],{"id":55,"indexDatabase":549,"url":68,"indexYears":69,"academicFieldIds":554,"indexDatabaseRanking":72},{"id":57,"createTime":58,"updateTime":59,"relativeEntities":550,"label":551,"description":552,"key":65,"publicationTags":553,"standard":18},[],{"EN":62,"VI":62},{"EN":62,"VI":64},[67],[71],{"id":74,"indexDatabase":556,"url":89,"indexYears":18,"academicFieldIds":561,"indexDatabaseRanking":18},{"id":76,"createTime":77,"updateTime":78,"relativeEntities":557,"label":558,"description":559,"key":85,"publicationTags":560,"standard":18},[],{"EN":81,"VI":81},{"VI":83,"EN":84},[87,88],[91],{"volume":563,"pages":565},{"VOID":564},"68",{"VOID":566},"955-965","2005-09-01",2005,{"id":570,"createTime":571,"updateTime":572,"relativeEntities":573,"slug":574,"properties":575,"entityType":109,"verifyStatus":110,"verifyTime":572,"verifyNote":111,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":582,"fullTextUrl":18,"authors":583,"publicationType":182,"publisherRelationship":599,"citationCount":18,"citationInfo":18,"publishDate":627,"publishYear":628,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":213},"b6fca133-90e3-483b-8e34-271359d22ac5","2024-02-09T16:50:05.115+00:00","2024-12-23T23:58:28.573+00:00",[],"Programmed-anti-inflammatory-macrophages-protect-against-AKI-and-promote-repair-through-trophic-actions",{"references":576,"title":578,"doi":580},{"VOID":577},"Allgren, 1997, Anaritide in acute tubular necrosis. Auriculin Anaritide Acute Renal Failure Study Group, N Engl J Med, 336, 828, 10.1056\u002FNEJM199703203361203\nHirschberg, 1999, Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure, Kidney Int, 55, 2423, 10.1046\u002Fj.1523-1755.1999.00463.x\nEndre, 2011, Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial), Kidney Int, 77, 1020, 10.1038\u002Fki.2010.25\nTogel, 2010, Mesenchymal stem cells: a new therapeutic tool for AKI, Nat Rev Nephrol, 6, 179, 10.1038\u002Fnrneph.2009.229\nDuffield, 2010, Macrophages and kidney disease: macrophages and immunological inflammation of the kidney, Semin Nephrol, 30, 234, 10.1016\u002Fj.semnephrol.2010.03.003\nLee, 2011, Distinct macrophage phenotypes contribute to kidney injury and repair, J Am Soc Nephrol, 22, 317, 10.1681\u002FASN.2009060615\nWilson, 2002, Bone-marrow-derived macrophages genetically modified to produce IL-10 reduce injury in experimental glomerulonephritis, Mol Ther, 6, 710, 10.1006\u002Fmthe.2002.0802\nNemeth, 2009, Bone marrow stromal cells attenuate sepsis via prostaglandin E2-dependent reprogramming of host macrophages to increase their interleukin-10 production, Nat Med, 15, 42, 10.1038\u002Fnm.1905\nTogel, 2005, Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms, Am J Physiol Renal Physiol, 289, F31, 10.1152\u002Fajprenal.00007.2005\nJung, 2012, Infusion of IL-10–expressing cells protects against renal ischemia through induction of lipocalin-2, Kidney Int, 81, 969, 10.1038\u002Fki.2011.446\nLee, 2002, Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice, Nat Med, 8, 240, 10.1038\u002Fnm0302-240",{"EN":579},"Programmed anti-inflammatory macrophages protect against AKI and promote repair through trophic actions",{"VOID":581},"10.1038\u002Fki.2012.9","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0085253815552125",[584],{"id":585,"sortIndex":19,"researcher":18,"roles":586,"affiliations":587,"properties":596},"c04dec62-3cce-4652-9bd3-fdd8830357a2",[117],[588],{"id":18,"sortIndex":19,"affiliation":589,"properties":18},{"id":590,"createTime":591,"updateTime":591,"relativeEntities":592,"slug":18,"properties":593,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"1c655cc8-de4b-4c76-a247-3697e8826018","2024-02-09T16:50:05.130+00:00",[],{"title":594},{"VI":595},"Division of Nephrology, University of Utah and George E. Wahlen Veterans Affairs Medical Centers, Salt Lake City, Utah, USA",{"title":597},{"VI":598},"Christof Westenfelder",{"url":582,"publisher":600,"properties":622},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":601,"slug":10,"properties":602,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":605,"manageAffiliations":606,"indexDatabases":607,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":603,"title":604},{"VOID":13},{"EN":15},[],[],[608,615],{"id":55,"indexDatabase":609,"url":68,"indexYears":69,"academicFieldIds":614,"indexDatabaseRanking":72},{"id":57,"createTime":58,"updateTime":59,"relativeEntities":610,"label":611,"description":612,"key":65,"publicationTags":613,"standard":18},[],{"EN":62,"VI":62},{"EN":62,"VI":64},[67],[71],{"id":74,"indexDatabase":616,"url":89,"indexYears":18,"academicFieldIds":621,"indexDatabaseRanking":18},{"id":76,"createTime":77,"updateTime":78,"relativeEntities":617,"label":618,"description":619,"key":85,"publicationTags":620,"standard":18},[],{"EN":81,"VI":81},{"VI":83,"EN":84},[87,88],[91],{"volume":623,"pages":625},{"VOID":624},"81",{"VOID":626},"939-941","2012-05-01",2012,{"id":630,"createTime":631,"updateTime":632,"relativeEntities":633,"slug":634,"properties":635,"entityType":109,"verifyStatus":110,"verifyTime":632,"verifyNote":111,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":642,"fullTextUrl":18,"authors":643,"publicationType":182,"publisherRelationship":707,"citationCount":18,"citationInfo":18,"publishDate":735,"publishYear":736,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":213},"ff5da42f-af24-4b69-8d06-7b5609d301eb","2024-01-26T13:47:39.892+00:00","2024-12-21T23:58:27.006+00:00",[],"Flow-mediated-vasodilation-and-distensibility-of-the-brachial-artery-in-renal-allograft-recipients",{"references":636,"title":638,"doi":640},{"VOID":637},"Nichols, 1980, Accelerated arteriosclerosis in long-term dialysis and renal transplant patients: Fact or fiction?, Lancet, 1, 276, 10.1016\u002FS0140-6736(80)90777-1\nMaiorca, 1995, Which treatment for which patient in the future? Possible modifications in CAPD, Nephrol Dial Transplant, 10, 20, 10.1093\u002Fndt\u002F10.supp7.20\nPort, 1993, Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients, JAMA, 270, 1339, 10.1001\u002Fjama.1993.03510110079036\nRostand, 1991, Cardiovascular complications in renal failure, J Am Soc Nephrol, 2, 1053, 10.1681\u002FASN.V261053\nBarenbrock, 1993, Effect of long-term hemodialysis on arterial compliance in end-stage renal failure, Nephron, 65, 249, 10.1159\u002F000187483\nBarenbrock, 1994, Studies of the vessel wall properties in hemodialysis patients, Kidney Int, 45, 1397, 10.1038\u002Fki.1994.182\nLondon, 1996, Cardiac and arterial interactions in end-stage renal disease, Kidney Int, 50, 600, 10.1038\u002Fki.1996.355\nCelermajer, 1992, Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis, Lancet, 340, 1111, 10.1016\u002F0140-6736(92)93147-F\nKari, 1997, Physiology and biochemistry of endothelial function in children with chronic renal failure, Kidney Int, 52, 468, 10.1038\u002Fki.1997.354\nVanGuldener, 1997, Endothelium-dependent vasodilatation and distensibility of large arteries in chronic hemodialysis patients, Nephrol Dial Transplant, 12, 14\nVallance, 1992, Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure, Lancet, 339, 572, 10.1016\u002F0140-6736(92)90865-Z\nJoannides, 1995, Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo, Circulation, 91, 1314, 10.1161\u002F01.CIR.91.5.1314\nNakamura, 1997, Flow-mediated vasodilation of a conduit artery in relation to downstream peripheral tissue blood flow during reactive hyperemia in humans, Jpn Circ J, 61, 772, 10.1253\u002Fjcj.61.772\nPohl, 1986, Crucial role of endothelium in the vasodilator response to increased flow in vivo, Hypertension, 8, 37, 10.1161\u002F01.HYP.8.1.37\nHoeks, 1991, Technical aspects of compliance assessment, Arch Mal Coeur Vaiss, 84, 77\nKool, 1994, Evaluation of reproducibility of a vessel wall movement detector system for assessment of large artery properties, Cardiovasc Res, 28, 610, 10.1093\u002Fcvr\u002F28.5.610\nMalyszko, 1996, The coagulo-lytic system and endothelial function in cyclosporine-treated kidney allograft recipients, Transplantation, 62, 828, 10.1097\u002F00007890-199609270-00021\nMacLenachan, 1990, Early evidence of endothelial vasodilator dysfunction at coronary branch points, Circulation, 82, 1169, 10.1161\u002F01.CIR.82.4.1169\nFish, 1988, Responses of coronary arteries in cardiac transplant patients to acetylcholine, J Clin Invest, 81, 21, 10.1172\u002FJCI113297\nSorensen, 1994, Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein (a) level, J Clin Invest, 93, 50, 10.1172\u002FJCI116983\nLondon, 1997, Atherosclerosis and arteriosclerosis in chronic renal failure, Kidney Int, 51, 1678, 10.1038\u002Fki.1997.233\nSchmieder, 1997, Is endothelial function of the radial artery altered in human essential hypertension?, Am J Hypertens, 10, 323, 10.1016\u002FS0895-7061(96)00414-1\nArcaro, 1995, Non-invasive detection of early endothelial dysfunction in hypercholesterolaemic subjects, Atherosclerosis, 114, 247, 10.1016\u002F0021-9150(94)05489-6\nZenere, 1995, Noninvasive detection of functional alterations of the arterial wall in IDDM patients with and without microalbuminuria, Diabetes Care, 18, 975, 10.2337\u002Fdiacare.18.7.975\nBarenbrock, 1995, Different effects of hypertension, atherosclerosis and hyperlipidemia on arterial distensibility, J Hypertens, 13, 1712\nKuriyama, 1996, Endothelial cell dysfunction in patients with impaired renal function, Nippon Jinzo Gakkai Shi, 38, 372\nHaaber, 1995, Vascular endothelial cell function and cardiovascular risk factors in patients with chronic renal failure, J Am Soc Nephrol, 5, 1581, 10.1681\u002FASN.V581581\nIiyama, 1996, Impaired endothelial function with essential hypertension assessed by ultrasonography, Am Heart J, 132, 779, 10.1016\u002FS0002-8703(96)90311-7\nSafar, 1987, Arterial and venous compliance in sustained essential hypertension, Hypertension, 10, 133, 10.1161\u002F01.HYP.10.2.133\nLuscher, 1996, Endothelial function as an end-point in interventional trials: Concepts, methods and current data, J Hypertens, 14, S111, 10.1097\u002F00004872-199609002-00020\nFerro, 1997, Endothelial dysfunction and hypertension, Drugs, 53, 30, 10.2165\u002F00003495-199700531-00006\nDohi, 1996, Benidipine improves endothelial function in renal resistance arteries of hypertensive rats, Hypertension, 28, 58, 10.1161\u002F01.HYP.28.1.58\nSavolainen, 1996, Effects of angiotensin-converting enzyme inhibition versus beta-adrenergic blockade on aortic stiffness in essential hypertension, J Cardiovasc Pharmacol, 27, 99, 10.1097\u002F00005344-199601000-00016\nVanBortel, 1995, Effects of antihypertensive agents on local arterial distensibility and compliance, Hypertension, 26, 531, 10.1161\u002F01.HYP.26.3.531\nPickkers, 1997, Direct vascular effects of furosemide in humans, Circulation, 96, 1847, 10.1161\u002F01.CIR.96.6.1847\nTing, 1997, Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia, Circulation, 95, 2617, 10.1161\u002F01.CIR.95.12.2617\nCohen, 1988, Loss of selective endothelial vasoactive functions caused by hypercholesterolemia in pig coronary arteries, Circ Res, 63, 903, 10.1161\u002F01.RES.63.5.903\nGiannattasio, 1996, Impaired radial artery compliance in normotensive subjects with familial hypercholesterolemia, Atherosclerosis, 124, 249, 10.1016\u002F0021-9150(96)05834-0\nGallego, 1994, Mechanisms of the endothelial toxicity of cyclosporin A: Role of nitric oxide, cGMP, and Ca2+, Circ Res, 74, 477, 10.1161\u002F01.RES.74.3.477\nvan den Dorpel, 1998, Forearm vasorelaxation in hypertensive renal transplant patients: The impact of withdrawal of cyclosporine, J Hypertens, 16, 331, 10.1097\u002F00004872-199816030-00010",{"EN":639},"Flow-mediated vasodilation and distensibility of the brachial artery in renal allograft recipients",{"VOID":641},"10.1046\u002Fj.1523-1755.1999.0550031104.x","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0085253815460600",[644,659,671,683,695],{"id":645,"sortIndex":132,"researcher":18,"roles":646,"affiliations":647,"properties":656},"7155130c-b233-489f-a34a-8c235515f0ca",[117],[648],{"id":18,"sortIndex":19,"affiliation":649,"properties":18},{"id":650,"createTime":651,"updateTime":651,"relativeEntities":652,"slug":18,"properties":653,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"a25596ad-2565-4ccf-8680-843668f95d45","2023-12-26T07:36:20.109+00:00",[],{"title":654},{"VI":655},"Department of Internal Medicine D, University of Münster, Münster, Germany",{"title":657},{"VI":658},"Karl-Heinz Rahn",{"id":660,"sortIndex":158,"researcher":18,"roles":661,"affiliations":662,"properties":668},"5ebe5c7c-dcf1-4ebb-a73f-d7dbe2e58bc9",[117],[663],{"id":18,"sortIndex":19,"affiliation":664,"properties":18},{"id":650,"createTime":651,"updateTime":651,"relativeEntities":665,"slug":18,"properties":666,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":667},{"VI":655},{"title":669},{"VI":670},"Michael Barenbrock",{"id":672,"sortIndex":19,"researcher":18,"roles":673,"affiliations":674,"properties":680},"c4ead993-b2e1-4dca-bee5-7c65d84f868a",[117],[675],{"id":18,"sortIndex":19,"affiliation":676,"properties":18},{"id":650,"createTime":651,"updateTime":651,"relativeEntities":677,"slug":18,"properties":678,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":679},{"VI":655},{"title":681},{"VI":682},"Martin Hausberg",{"id":684,"sortIndex":145,"researcher":18,"roles":685,"affiliations":686,"properties":692},"60a22d3a-691f-4ffd-9567-814bda381b83",[117],[687],{"id":18,"sortIndex":19,"affiliation":688,"properties":18},{"id":650,"createTime":651,"updateTime":651,"relativeEntities":689,"slug":18,"properties":690,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":691},{"VI":655},{"title":693},{"VI":694},"Markus Kosch",{"id":696,"sortIndex":171,"researcher":18,"roles":697,"affiliations":698,"properties":704},"d97d0407-feb0-4137-b028-1f2b38e534f2",[117],[699],{"id":18,"sortIndex":19,"affiliation":700,"properties":18},{"id":650,"createTime":651,"updateTime":651,"relativeEntities":701,"slug":18,"properties":702,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":703},{"VI":655},{"title":705},{"VI":706},"Klaus Kisters",{"url":642,"publisher":708,"properties":730},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":709,"slug":10,"properties":710,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":713,"manageAffiliations":714,"indexDatabases":715,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":711,"title":712},{"VOID":13},{"EN":15},[],[],[716,723],{"id":55,"indexDatabase":717,"url":68,"indexYears":69,"academicFieldIds":722,"indexDatabaseRanking":72},{"id":57,"createTime":58,"updateTime":59,"relativeEntities":718,"label":719,"description":720,"key":65,"publicationTags":721,"standard":18},[],{"EN":62,"VI":62},{"EN":62,"VI":64},[67],[71],{"id":74,"indexDatabase":724,"url":89,"indexYears":18,"academicFieldIds":729,"indexDatabaseRanking":18},{"id":76,"createTime":77,"updateTime":78,"relativeEntities":725,"label":726,"description":727,"key":85,"publicationTags":728,"standard":18},[],{"EN":81,"VI":81},{"VI":83,"EN":84},[87,88],[91],{"volume":731,"pages":733},{"VOID":732},"55",{"VOID":734},"1104-1110","1999-03-01",1999,{"id":738,"createTime":739,"updateTime":740,"relativeEntities":741,"slug":742,"properties":743,"entityType":109,"verifyStatus":110,"verifyTime":740,"verifyNote":111,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":750,"fullTextUrl":18,"authors":751,"publicationType":182,"publisherRelationship":793,"citationCount":18,"citationInfo":18,"publishDate":821,"publishYear":822,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":213},"1dea2d8a-4669-4160-8544-1dd757d0ff52","2024-01-18T22:04:51.029+00:00","2024-12-08T23:58:25.956+00:00",[],"Renal-handling-of-beta-2-microglobulin-in-the-human-neonate",{"references":744,"title":746,"doi":748},{"VOID":745},"Smith, 1951, 492\nFetterman, 1965, The growth and maturation of human glomeruli and proximal convolutions from term to adulthood, Pediatrics, 35, 601\nEdelmann, 1969, The maturing kidney, J Pediatr, 75, 509, 10.1016\u002FS0022-3476(69)80284-2\nOh, 1981, Renal functions and clinical disorders in the neonate, Clin Perinatol, 8, 215, 10.1016\u002FS0095-5108(18)31075-3\nAperia, 1979, Beta-2-microglobulin, an indicator of renal tubular maturation and dysfunction in the newborn, Acta Paediatr Scand, 68, 669, 10.1111\u002Fj.1651-2227.1979.tb18436.x\nMassry, 1969, The influence of extracellular volume expansion on renal phosphate reabsorption in the dog, J Clin Invest, 48, 1237, 10.1172\u002FJCI106088\nKurtzman, 1970, Regulation of renal bicarbonate reabsorption by extracellular volume, J Clin Invest, 49, 586, 10.1172\u002FJCI106269\nKnight, 1977, Renal sodium reabsorption following induction of and recovery from volume expansion, Am J Physiol, 233, F416\nRobson, 1968, The influence of saline loading on renal glucose reabsorption in the rat, J Clin Invest, 47, 329, 10.1172\u002FJCI105728\nArant, 1978, Glomerulotubular balance following saline loading in the developing canine kidney, Am J Physiol, 235, F417\nTudvad, 1953, The maximal tubular transfer of glucose and para-amino-hippurate in premature infants, Acta Paediatr Scand, 42, 337, 10.1111\u002Fj.1651-2227.1953.tb05601.x\nBrodehl, 1972, Maximal tubular reabsorption of glucose in infants and children, Acta Paediatr Scand, 61, 413, 10.1111\u002Fj.1651-2227.1972.tb15856.x\nArant, 1978, Developmental patterns of renal functional maturation compared in the human neonate, J Pediatr, 92, 705, 10.1016\u002FS0022-3476(78)80133-4\nAperia, 1981, Postnatal development of renal function in pre-term and full-term infants, Acta Paediatr Scand, 70, 183, 10.1111\u002Fj.1651-2227.1981.tb05539.x\nLubchenco, 1970, Assessment of gestational age and development at birth, Pediatr Clin North Am, 17, 125, 10.1016\u002FS0031-3955(16)32381-1\nGersh, 1937, The correlation of structure and function in the developing mesonephros and metanephros, Contrib Embryol, 153, 35\nCameron, 1938, Direct evidence of function in kidney of an early human fetus, Am J Physiol, 123, 482, 10.1152\u002Fajplegacy.1938.123.2.482\nPotter, 1943, Glomerular development in the kidney as an index of fetal maturity, J Pediatr, 22, 695, 10.1016\u002FS0022-3476(43)80226-2\nSiegel, 1976, Renal function as a marker of human fetal maturation, Acta Paediatr Scand, 65, 481, 10.1111\u002Fj.1651-2227.1976.tb04917.x\nSchardijn, 1979, Urinary β2-microglobulin in upper and lower urinarytract infections, Lancet, 1, 805, 10.1016\u002FS0140-6736(79)91320-5\nBerggard, 1968, Isolation and properties of a low molecular weight β2-globulin occurring in human biological fluids, J Biol Chem, 243, 4095, 10.1016\u002FS0021-9258(18)93284-9\nPeterson, 1969, Differentiation of glomerular, tubular, and normal proteinuria: determinations of urinary excretion of β2-microglobulin, albumin, and total protein, J Clin Invest, 48, 1189, 10.1172\u002FJCI106083\nBraren, 1979, Beta-2-microglobulin as renal diagnostic agent, Urology, 13, 624, 10.1016\u002F0090-4295(79)90385-6\nHall, 1982, The renal handling of beta2-microglobulin in the dog, Kidney Int, 22, 156, 10.1038\u002Fki.1982.147\nIesato, 1977, Renal tubular dysfunction in Minimata Disease, Ann Int Med, 86, 731, 10.7326\u002F0003-4819-86-6-731\nSchentag, 1978, Early detection of aminoglycoside nephrotoxicity with urinary beta-2-microglobulin, J Med, 9, 201\nKithier, 1974, β2-microglobulin: Occurrence in fetal life and malignancy, Clin Chim Acta, 52, 293, 10.1016\u002F0009-8981(74)90113-2\nHall, 1974, Amniotic fluid beta-2-microglobulin concentration—an index of gestational age, Am J Obstet Gynecol, 120, 56, 10.1016\u002F0002-9378(74)90178-1\nJonasson, 1974, Content of β2-microglobulin and albumin in human amniotic fluid, Acta Obstet Gynecol Scand, 53, 49, 10.3109\u002F00016347409156888\nMoore, 1972, Renal reabsorption of bicarbonate in puppies: Effect of extracellular volume contraction on the renal threshold for bicarbonate, Pediatr Res, 6, 859, 10.1203\u002F00006450-197212000-00002\nRobillard, 1977, Influence of fetal extracellular volume contraction on renal reabsorption of bicarbonate in fetal lambs, Pediatr Res, 11, 649, 10.1203\u002F00006450-197705000-00006\nFriis-Hansen, 1957, Changes in body water compartments during growth, Acta Pediatr Scand, 46, 1\nSPITZER A: Renal physiology and functional development, in Pediatric Kidney Disease, edited by EDELMAN CM JR. Boston, Little, Brown and Company, Inc., vol. 1, p. 54\nKleinman, 1975, Renal sodium reabsorption during saline loading and distal blockade in newborn dogs, Am J Physiol, 228, 1403, 10.1152\u002Fajplegacy.1975.228.5.1403\nDawson, 1981, Urinary β2-microglobulin in the newborn, Aust Paediatr J, 17, 44\nCejka, 1973, Serum β2-microglobulin levels in normal children and sex-linked agammaglobulinemia patients, Clin Chim Acta, 47, 59, 10.1016\u002F0009-8981(73)90059-4\nvan Oort, 1980, Beta-2-microglobulin clearance, an indicator of renal tubular maturation, Int J Pediatr Nephrol, 1, 80",{"EN":747},"Renal handling of beta-2-microglobulin in the human neonate",{"VOID":749},"10.1038\u002Fki.1983.167","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0085253815330374",[752,769,781],{"id":753,"sortIndex":145,"researcher":18,"roles":754,"affiliations":755,"properties":766},"d27683b5-57e4-4a5b-83d6-e9cec2948833",[117],[756],{"id":18,"sortIndex":19,"affiliation":757,"properties":18},{"id":758,"createTime":759,"updateTime":760,"relativeEntities":761,"slug":762,"properties":763,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"011837fe-1a53-4701-a58c-6c399b3ebab8","2024-01-18T22:04:51.073+00:00","2025-06-11T14:34:05.604+00:00",[],"Department-of-Pediatrics-The-University-of-Texas-Health-Science-Center-at-Dallas-and-Newborn-Nurseries-Parkland-Memorial-Hospital-Dallas-Texas",{"title":764},{"VI":765},"Department of Pediatrics, The University of Texas Health Science Center at Dallas, and Newborn Nurseries, Parkland Memorial Hospital, Dallas, Texas",{"title":767},{"VI":768},"W D Engle",{"id":770,"sortIndex":171,"researcher":18,"roles":771,"affiliations":772,"properties":778},"5b557024-8413-4d8d-84f2-61e2448611b2",[117],[773],{"id":18,"sortIndex":19,"affiliation":774,"properties":18},{"id":758,"createTime":759,"updateTime":760,"relativeEntities":775,"slug":762,"properties":776,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":777},{"VI":765},{"title":779},{"VI":780},"Billy S. Arant",{"id":782,"sortIndex":19,"researcher":18,"roles":783,"affiliations":784,"properties":790},"3cb90c81-2124-4c1e-a9cb-168e974df630",[117],[785],{"id":18,"sortIndex":19,"affiliation":786,"properties":18},{"id":758,"createTime":759,"updateTime":760,"relativeEntities":787,"slug":762,"properties":788,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":789},{"VI":765},{"title":791},{"VI":792},"William D. Engle",{"url":750,"publisher":794,"properties":816},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":795,"slug":10,"properties":796,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":799,"manageAffiliations":800,"indexDatabases":801,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":797,"title":798},{"VOID":13},{"EN":15},[],[],[802,809],{"id":55,"indexDatabase":803,"url":68,"indexYears":69,"academicFieldIds":808,"indexDatabaseRanking":72},{"id":57,"createTime":58,"updateTime":59,"relativeEntities":804,"label":805,"description":806,"key":65,"publicationTags":807,"standard":18},[],{"EN":62,"VI":62},{"EN":62,"VI":64},[67],[71],{"id":74,"indexDatabase":810,"url":89,"indexYears":18,"academicFieldIds":815,"indexDatabaseRanking":18},{"id":76,"createTime":77,"updateTime":78,"relativeEntities":811,"label":812,"description":813,"key":85,"publicationTags":814,"standard":18},[],{"EN":81,"VI":81},{"VI":83,"EN":84},[87,88],[91],{"volume":817,"pages":819},{"VOID":818},"24",{"VOID":820},"358-363","1983-09-01",1983,{"id":824,"createTime":825,"updateTime":826,"relativeEntities":827,"slug":828,"properties":829,"entityType":109,"verifyStatus":110,"verifyTime":826,"verifyNote":111,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":836,"fullTextUrl":18,"authors":837,"publicationType":182,"publisherRelationship":853,"citationCount":18,"citationInfo":18,"publishDate":881,"publishYear":882,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":213},"f0153a53-647d-41ea-8aa0-3c3a7cb9fd9b","2024-01-26T19:14:12.331+00:00","2024-12-17T23:57:41.268+00:00",[],"Leukocyte-derived-microvesicles-dock-on-glomerular-endothelial-cells-stardust-in-the-kidney",{"references":830,"title":832,"doi":834},{"VOID":831},"Colombo, 2014, Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles, Annu Rev Cell Dev Biol, 30, 255, 10.1146\u002Fannurev-cellbio-101512-122326\nKahn, 2017, Microvesicle transfer of kinin B1-receptors is a novel inflammatory mechanism in vasculitis, Kidney Int, 91, 96, 10.1016\u002Fj.kint.2016.09.023\nKanada, 2015, Differential fates of biomolecules delivered to target cells via extracellular vesicles, Proc Natl Acad Sci U S A, 112, E1433, 10.1073\u002Fpnas.1418401112\nTricarico C, Clancy J, D'Souza-Schorey C. Biology and biogenesis of shed microvesicles [e-pub ahead of print]. Small GTPases. http:\u002F\u002Fdx.doi.org\u002F10.1080\u002F21541248.2016.1215283. Accessed November 6, 2016.\nZhang, 2016, Extracellular vesicles in diagnosis and therapy of kidney diseases, Am J Physiol Renal Physiol, 311, F844, 10.1152\u002Fajprenal.00429.2016\nDistler, 2006, Microparticles as mediators of cellular cross-talk in inflammatory disease, Autoimmunity, 39, 683, 10.1080\u002F08916930601061538\nKoppler, 2006, Differential mechanisms of microparticle transfer to B cells and monocytes: anti-inflammatory properties of microparticles, Eur J Immunol, 36, 648, 10.1002\u002Feji.200535435\nMack, 2000, Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: a mechanism for cellular human immunodeficiency virus 1 infection, Nat Med, 6, 769, 10.1038\u002F77498\nGonzalez, 2012, Microparticle-mediated transfer of the viral receptors CAR and CD46, and the CFTR channel in a CHO cell model confers new functions to target cells, PLoS One, 7, e52326, 10.1371\u002Fjournal.pone.0052326",{"EN":833},"Leukocyte-derived microvesicles dock on glomerular endothelial cells: stardust in the kidney",{"VOID":835},"10.1016\u002Fj.kint.2016.09.047","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0085253816306147",[838],{"id":839,"sortIndex":19,"researcher":18,"roles":840,"affiliations":841,"properties":850},"1837bf22-6750-4e5a-8aa4-5ff47ee8c16e",[117],[842],{"id":18,"sortIndex":19,"affiliation":843,"properties":18},{"id":844,"createTime":845,"updateTime":845,"relativeEntities":846,"slug":18,"properties":847,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"efdba051-1574-42ec-82a9-6b57f84272c2","2024-01-26T19:14:12.343+00:00",[],{"title":848},{"VI":849},"University Hospital Regensburg, 93042 Regensburg, Germany",{"title":851},{"VI":852},"Matthias Mack",{"url":836,"publisher":854,"properties":876},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":855,"slug":10,"properties":856,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":859,"manageAffiliations":860,"indexDatabases":861,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":857,"title":858},{"VOID":13},{"EN":15},[],[],[862,869],{"id":55,"indexDatabase":863,"url":68,"indexYears":69,"academicFieldIds":868,"indexDatabaseRanking":72},{"id":57,"createTime":58,"updateTime":59,"relativeEntities":864,"label":865,"description":866,"key":65,"publicationTags":867,"standard":18},[],{"EN":62,"VI":62},{"EN":62,"VI":64},[67],[71],{"id":74,"indexDatabase":870,"url":89,"indexYears":18,"academicFieldIds":875,"indexDatabaseRanking":18},{"id":76,"createTime":77,"updateTime":78,"relativeEntities":871,"label":872,"description":873,"key":85,"publicationTags":874,"standard":18},[],{"EN":81,"VI":81},{"VI":83,"EN":84},[87,88],[91],{"volume":877,"pages":879},{"VOID":878},"91",{"VOID":880},"13-15","2017-01-01",2017,{"id":884,"createTime":885,"updateTime":886,"relativeEntities":887,"slug":888,"properties":889,"entityType":109,"verifyStatus":110,"verifyTime":886,"verifyNote":111,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":896,"fullTextUrl":18,"authors":897,"publicationType":182,"publisherRelationship":949,"citationCount":18,"citationInfo":18,"publishDate":977,"publishYear":568,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":213},"4e5bea30-ac6a-4348-aea4-145c9271372c","2023-11-30T00:43:03.865+00:00","2025-02-15T23:57:37.926+00:00",[],"Impact-of-gastric-acid-suppressants-on-cytochrome-P450-3A4-and-P-glycoprotein-Consequences-for-FK506-assimilation",{"references":890,"title":892,"doi":894},{"VOID":891},"Watkins, 1992, Drug metabolism by cytochromes P450 in the liver and small bowel, Gastrointestinal Pharmacol, 23, 511\nLo, 1999, P-glycoprotein and drug therapy in organ transplantation, J Clin Pharmacol, 39, 995, 10.1177\u002F00912709922011755\nDe Wildt, 1999, Cytochrome P450 3A. Ontogeny and drug disposition, Clin Pharmacokinet, 37, 485, 10.2165\u002F00003088-199937060-00004\nSeifeldin, 1995, Drug interactions in transplantation, Clin Ther, 17, 1043, 10.1016\u002F0149-2918(95)80084-0\nChristians, 2002, Mechanisms of clinically relevant drug interactions associated with tacrolimus, Clin Pharmacokinet, 41, 813, 10.2165\u002F00003088-200241110-00003\nVan Roermund, 1982, Cimetidine prophylaxis after renal transplantation, Clin Nephrol, 18, 39\nWalter, 1984, Effect of cimetidine on upper gastrointestinal bleeding after renal transplantation: a prospective study, BMJ, 289, 1175, 10.1136\u002Fbmj.289.6453.1175\nSkala, 1997, Prophylaxis of acute gastroduodenal bleeding after renal transplantation, Transpl Int, 10, 375, 10.1111\u002Fj.1432-2277.1997.tb00932.x\nFuruta, 2001, Inhibition of drug metabolism in human liver microsomes by nizatidine, cimetidin and omeprazole, Xenobiotica, 31, 1, 10.1080\u002F00498250110035615\nSzutowski, 2002, In vivo effect of 5- and 8-methoxypsoralens and cimetidin on R,S-warfarin metabolism in rat, J Appl Toxicol, 22, 327, 10.1002\u002Fjat.867\nLindell, 2003, Variable expression of CYP and PGP genes in the human small intestine, Eur J Clin Invest, 33, 493, 10.1046\u002Fj.1365-2362.2003.01154.x\nRendic, 1984, Cimetidine and ranitidine: Their interaction with human and pig liver microsomes and with purified cytochrome P-450, Eur J Drug Metab Pharmacokinet, 9, 195, 10.1007\u002FBF03189641\nMion, 1995, Aminopyrine breath test: Development of a 13C-breath test for quantitative assessment of liver function in humans, Hepato-Gastroenterology, 42, 931\nLemahieu, 2003, Measurement of hepatic and intestinal cyp 3A4 and P-glycoprotein activity by means of a combined po and iv C14 erythromycin breath and urine test, Am J Physiol Gastrointest Liver Physiol, 285, 470, 10.1152\u002Fajpgi.00028.2003\nBoswell, 1998, Tacrolimus pharmacokinetics in BMT patients, Bone Marrow Transplant, 21, 23, 10.1038\u002Fsj.bmt.1701054\nGhoos, 1993, Measurement of gastric emptying rate of solids by means of a carbon labbelled octanoic breath test, Gastroenterology, 104, 1640, 10.1016\u002F0016-5085(93)90640-X\nEvenepoel, 1997, Production of egg proteins, enriched with L-leucine-13C1, for the study of protein assimilation in humans using the breath test technique, J Nutr, 127, 327, 10.1093\u002Fjn\u002F127.2.327\nMaes, 1998, Gastric emptying flow curves separated from carbon-labeled octanoic acid breath test results, Am J Physiol Gastrointest Liver Physiol, 275, 169, 10.1152\u002Fajpgi.1998.275.1.G169\nIrving, 1982, The aminopyrin breath test as a measure of liver function, J Lab Clin Med, 100, 3563\nPlosker, 2000, Tacrolimus: A further update of its pharmacology and therapeutic use in the management of organ transplantation, Drugs, 59, 323, 10.2165\u002F00003495-200059020-00021\nUndre, 1998, European Tacrolimus Multicentre Renal Study Group. Factors affecting the pharmacokinetics of tacrolimus in the first year after renal transplantation, Transplant Proc, 30, 1261, 10.1016\u002FS0041-1345(98)00234-6\nShimada, 2002, Lowered blood concentration of tacrolimus and its recovery with changes in expression of cyp3A and P-glycoprotein after high-dose steroid therapy, Transplantation, 74, 1419, 10.1097\u002F00007890-200211270-00014\nAndreev, 1999, A rise in plasma creatinine that is not a sign of renal failure: Which drugs can be responsible?, J Intern Med, 246, 247, 10.1046\u002Fj.1365-2796.1999.00515.x\nNiwa, 1999, Contribution of human hepatic cytochrome P450s and steroidogenic CYP17 to the N-demethylation of aminopyrine, Xenobiotica, 29, 187, 10.1080\u002F004982599238731\nParker, 1997, Lack of inhibitory effect of cimetidine on caffeine metabolism in children using the caffeine breath test, Br J Clin Pharmacol, 43, 467, 10.1046\u002Fj.1365-2125.1997.00589.x\nLoi, 1997, Aging and drug interactions. III. Individual and combined effects of cimetidin and cimetidin and ciprofloxacin on theophyllin metabolism in healthy male and female nonsmokers, J Pharmacol Exp Ther, 280, 627\nMojtahedzadeh, 2003, Determination of theophyllin clearance after cimetidin infusion in critically ill patients, J Infus Nurs, 26, 234, 10.1097\u002F00129804-200307000-00008\nO'Reilly, 1984, Comparative interaction of cimetidin and ranitidin with racemic warfarin in man, Arch Intern Med, 144, 989, 10.1001\u002Farchinte.1984.00350170143024\nHeagerty, 1981, Influence of cimetidin on pharmacokinetics of propranolol, BMJ, 13, 1917, 10.1136\u002Fbmj.282.6280.1917\nCuri-Pedrosa, 1994, Omeprazole and lansoprazole are mixed inducers of CYP1A and CYP3A in human hepatocytes in primary culture, J Pharmacol Exp Ther, 269, 384\nRaucy, 2003, Regulation of CYP3A4 expression in human hepatocytes by pharmaceuticals and natural products, Drug Metab Dispos, 31, 533, 10.1124\u002Fdmd.31.5.533\nReichenspurner, 1994, Changes of resorption and metabolism of cyclosporine after heart transplantation by the influence of gastrointestinal agents, Transplant Proc, 26, 2800\nShaefer, 1995, Evaluation of the pharmacokinetic interaction between cimetidine or famotidine and cyclosporine in healthy men, Ann Pharmacother, 29, 1088, 10.1177\u002F106002809502901102\nPuff, 1992, The effect of cimetidine on cyclosporine A levels in liver transplant recipients: A preliminary report, Am J Gastroenterol, 87, 287\nBarri, 1996, Cimetidine or ranitidine in renal transplant patients receiving cyclosporine, Clin Transplant, 10, 34\nBlohme, 1993, A study of the interaction between omeprazole and cyclosporine in renal transplant patients, Br J Clin Pharmacol, 35, 156\nLemahieu, 2004, CYP3A4 and P-glycoprotein activity in healthy controls and transplant patients on cyclosporine vs. tacrolimus vs. sirolimus, Am J Tranplant, 4, 1514, 10.1111\u002Fj.1600-6143.2004.00539.x",{"EN":893},"Impact of gastric acid suppressants on cytochrome P450 3A4 and P-glycoprotein: Consequences for FK506 assimilation",{"VOID":895},"10.1111\u002Fj.1523-1755.2005.00182.x","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0085253815505632",[898,913,925,937],{"id":899,"sortIndex":171,"researcher":18,"roles":900,"affiliations":901,"properties":910},"d9adce15-7103-4be5-8f79-b24ca571eb29",[117],[902],{"id":18,"sortIndex":19,"affiliation":903,"properties":18},{"id":904,"createTime":905,"updateTime":905,"relativeEntities":906,"slug":18,"properties":907,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"610377b1-43f3-47d9-b153-30f523675f22","2023-11-30T00:43:03.873+00:00",[],{"title":908},{"VI":909},"Division of Nephrology and Laboratory of Digestion and Absorption, Department of Medicine, University Hospital Gasthuisberg, University of Leuven, Leuven, Belgium",{"title":911},{"VI":912},"Bart D. Maes",{"id":914,"sortIndex":19,"researcher":18,"roles":915,"affiliations":916,"properties":922},"04242385-be20-44a4-9fd9-b8f50425c44c",[117],[917],{"id":18,"sortIndex":19,"affiliation":918,"properties":18},{"id":904,"createTime":905,"updateTime":905,"relativeEntities":919,"slug":18,"properties":920,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":921},{"VI":909},{"title":923},{"VI":924},"Wim P.D. Lemahieu",{"id":926,"sortIndex":145,"researcher":18,"roles":927,"affiliations":928,"properties":934},"1ba20545-a1b5-4530-acaa-bad0e5596b71",[117],[929],{"id":18,"sortIndex":19,"affiliation":930,"properties":18},{"id":904,"createTime":905,"updateTime":905,"relativeEntities":931,"slug":18,"properties":932,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":933},{"VI":909},{"title":935},{"VI":936},"Kristin Verbeke",{"id":938,"sortIndex":132,"researcher":18,"roles":939,"affiliations":940,"properties":946},"1f7179bc-47db-4aa7-8a76-14c191bb4101",[117],[941],{"id":18,"sortIndex":19,"affiliation":942,"properties":18},{"id":904,"createTime":905,"updateTime":905,"relativeEntities":943,"slug":18,"properties":944,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":945},{"VI":909},{"title":947},{"VI":948},"Yves Vanrenterghem",{"url":896,"publisher":950,"properties":972},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":951,"slug":10,"properties":952,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":955,"manageAffiliations":956,"indexDatabases":957,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":953,"title":954},{"VOID":13},{"EN":15},[],[],[958,965],{"id":55,"indexDatabase":959,"url":68,"indexYears":69,"academicFieldIds":964,"indexDatabaseRanking":72},{"id":57,"createTime":58,"updateTime":59,"relativeEntities":960,"label":961,"description":962,"key":65,"publicationTags":963,"standard":18},[],{"EN":62,"VI":62},{"EN":62,"VI":64},[67],[71],{"id":74,"indexDatabase":966,"url":89,"indexYears":18,"academicFieldIds":971,"indexDatabaseRanking":18},{"id":76,"createTime":77,"updateTime":78,"relativeEntities":967,"label":968,"description":969,"key":85,"publicationTags":970,"standard":18},[],{"EN":81,"VI":81},{"VI":83,"EN":84},[87,88],[91],{"volume":973,"pages":975},{"VOID":974},"67",{"VOID":976},"1152-1160","2005-03-01"]